Citrus Sinensis ID: 037207


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050------1060------1070------1080------1090------1100------1110------1120------1130------1140------1150------1160------1170------1180------1190------1200------1210------1220------1230------1240------1250------1260------1270------1280------1290------1300------1310------1320------1330------1340------1350------1360------1370------1380------1390------1400------1410------1420------1430------1440------1450------1460------1470------1480------1490------1500------1510------1520------1530------1540------1550------1560------1570------1580------1590------1600------1610------1620------1630------1640------1650------1660------1670------1680------1690------1700------1710------1720------1730------1740------1750------1760------1770------1780------1790------1800------1810------1820------1830------1840------1850------1860------1870------1880------1890------1900------1910------1920------1930------1940------1950------1960------1970------1980------199
MLAKLSPWCIVYPTLVDVNAYEERPSEELQHILGCLRELYPRLIQDVELMINELGNLTVLWEELWLSTLQDLHADVMRRINVLKEEAARIAENATLSQSEKKKINAAKYSAMMAPIVVALERRLASTSRKPETPHEIWFHEEFGEQLKSAILNFKTPPASAAALGDVWRPFDNIAASLASHQRKSSVSLSEVAPQLSLLSSSDVPMPGFEKQVATSESDGGLTATLRGIVTIASFSEEVSILSTKTKPKKLVILGQMLLQAVNSFLRSSPATRSHSLGIRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQFSAIGAGNAKSSVPPPVPRPSDMFYGKIIPALKEKGIRRVISRRDWPHDVKRKVLLDLMKEVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIEWTRGDFHDDAAIGGEERKGMELAVSLSLFASRVQEIRVPLQEHHDLLLATLPAVELALERFADVLSQYELASALFYRADQERSNLVLHETSTKSMVAEANCNAEKIRASFEVQAREFAQAKAVVTEKAQEATTWMEQHGRILDALRGNLIPEINSCIKLSGSMDAFSLTSAVLVAGVPFSIVPEPTQVQCHDIDKDVSQLIAELDHGLSSVFIALQAYSLALQRILPLNYLTTTAVHGWAQVLQLSANAPSVDILSLARRQATELIVRIHGDNHDSIKQNHDDLRLKVEKYGVEIEKVEKECAELVNSIGSETESKAKDRFLLAFMKYMKSAGLVRKEDVSSSYQSGQLKNDGRKDAGLRGKQDENKEKLLSVLNVAVTHLYDEVKCRVLDIFSDSAGGIKGNNRMQLDFGTLFCEFDEQVEKCILVAGFVNELWQSIGRDMYDNDADIECPNYHFERNWASIFKTSLLACKTLVGQMTEVVLPDVMRSTISFNSEVMDAFGLVSQIRGSIDTTLEQLVEVELERASLVELEQSYFVKVGLITEQQLALEEAAVKGRDHLSWEEAEELASQEEACKAELNELHQTWNQRDMRSSSLMKQEADIRNALVSSERHFQSVISAEEFREPHILRSKALLAILVKPFMELESVDKTLASFCESVGSIPYGTPKLADLINSGRSISECIWNFGSLSNGHSFFIWKMGIIDSFLDSCVHDVAASVDQNLGFDQLFNVVKKKLEVQLQEHVGLYLKERVAPIILAFLDKEIEHLKKLTESTKELTADDAKKDTGAVRRVQLMLAEYCNAHETARAARSAASLMKRQVNEFREALHKTSLEIVQMEWMHDATLTPSYNSRITFQKYFSSDDDIYPIILNLSRPKLLETLQSSVTKIARSVESLQACERSSLTAEGQLERAMGWACGGPNSSAAGNSSTKTSGIPPEFHDHLMRRRQLLWEAREKASKIVNICMSVLDFEASRDGVFRTPGEVYPARVGVDARSWQQVYLNAVTKLEVAYHSFTCAEQEWKLAQSSMEAASNGLYSATNELCIASLKAKSASGDLQSTVLTMRDCAYEASAALTAFGRVSRVHTALTSESGSMLEEVLAITEDLHDVHSLGKEAAAINHSLMEDLSKANAVLLPLDSVLSKDVAAMSDAITSERETKMEVSPIHGQAIYQSYCLRVRDACQLLKPLLPSLMSSVKGLYSMLTRLARTASLHAGNLHKALEGLGESQEVKSQGVSLSRSDLTAADSSQFDEKGREAFSGSDSGSIKDDFLGVSGISLQDKGWISPPDSIYSSSSESAITSGEASLPDSSNNPVELTGQHPHGLNQDSGQSVSKRTEVNNTDSGSVKFTVDEPIEYFKAQESPTGEAVSVAVGSSQPLGNNSEVKFGVKDEVSSVNKVGIEEENNEDHVPNTHTVSRVARGKNAYAISVLRRVEMKLDGRDIVENRNLSIAEQVDHLLKQATSVDNLCNMYEGWTPWI
cccccccccHHHHHHHcccccccccHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHcccccEEccccccHHHccccccccccccccccccccccccccccccccEEEEEEccEEEEcccccccEEEEEEHHHHHHHHHHHHcccccccccccccccccccccccccccEEEccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEEEEEccccccccccccccccccccccHHHHHHHcccccccHHHHHHHHHHHHHHHcHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHccHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHccccccHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHccEEEEcHHHHHHHHcccHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHccHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHcccccccHHHHHHHHHccccccccccccHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcccHHHHHHcccccccc
ccccccccEEEEEEEEEcccccHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHHHcccccEccccccccccccccccccccccccEEEEEEcccEEEEEEccccccEEEEEHHHHHHHHHHHHHcccHHHcccccEEEEEEEEcccccccEEEccccHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHcccccHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccEEEcccccEEEEEccHHHHHHHHccccccccHHHHHHHHHHHHcccccEcEEHHHHHHHHHHHHcHHHHHHHHHHHHccccEEcccccccccccccccccccccccccHHHcccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHcHHHccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHcccccccccccHHHHHHHHHHccccEEEcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHcccccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHccccccHHEccccHHHccccEEEEEEHHHHHHHHHHHHHHHccHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHcccccccHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHcHccHHHHHHHcccccccEEEEEccccHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccEEEccccccccccccccHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHcccccccccEEEEEEEcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHEEEEHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccccccccEEEcccccccEccccccccccccHHHHHccccccccccccccccccEEEccccccccccccccccHHHHHHccccccEEEEccccccccccccHHccccccccHHHHHccccHHccccccccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHcHHHHHHHHccccccc
mlaklspwcivyptlvdvnayeerpseELQHILGCLRELYPRLIQDVELMINELGNLTVLWEELWLSTLQDLHADVMRRINVLKEEAARIAENATLSQSEKKKINAAKYSAMMAPIVVALERRLastsrkpetpheiwfHEEFGEQLKSAILnfktppasaaalgdvwrpfDNIAASLAShqrkssvslsevapqlsllsssdvpmpgfekqvatsesdggltATLRGIVTIASFSEEVSIlstktkpkKLVILGQMLLQAVNSFlrsspatrshslgiryysvtpisgraglIQWVDNVISIYSVFKSWQHRAQLAQFSaigagnakssvpppvprpsdmfygkIIPAlkekgirrvisrrdwphdvKRKVLLDLMKEVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILglgdrhldnilldfssgdivhidynvcfdkgqrlkvpeivpfRLTQTIEAALGltgiegtfRANCEAVVSVLRKNKDILLMLLEVFvwdpliewtrgdfhddaaiggeerKGMELAVSLSLFASRVQEIRVPLQEHHDLLLATLPAVELALERFADVLSQYELASALFYRADQERSNLVLHETSTKSMVAEANCNAEKIRASFEVQAREFAQAKAVVTEKAQEATTWMEQHGRILDALRGNLIPEINSCiklsgsmdafsLTSAVLVAgvpfsivpeptqvqchdiDKDVSQLIAELDHGLSSVFIALQAYSLALQRilplnyltttaVHGWAQVLQLsanapsvdILSLARRQATELIVRIhgdnhdsikqnHDDLRLKVEKYGVEIEKVEKECAELVNSIGSETESKAKDRFLLAFMKYMKSAGLvrkedvsssyqsgqlkndgrkdaglrgkqdenkEKLLSVLNVAVTHLYdevkcrvldifsdsaggikgnnrmqldfgTLFCEFDEQVEKCILVAGFVNELWQSIgrdmydndadiecpnyhfernwaSIFKTSLLACKTLVGQMTEVVLPDVMRSTISFNSEVMDAFGLVSQIRGSIDTTLEQLVEVELERASLVELEQSYFVKVGLITEQQLALEEAAVKGRDHLSWEEAEELASQEEACKAELNELHQTWNQRDMRSSSLMKQEADIRNALVSSERHFqsvisaeefrephiLRSKALLAILVKPFMELESVDKTLASFCEsvgsipygtpkladlinsGRSISECIWnfgslsnghsfFIWKMGIIDSFLDSCVHDVAAsvdqnlgfDQLFNVVKKKLEVQLQEHVGLYLKERVAPIILAFLDKEIEHLKKLTESTKEltaddakkdtGAVRRVQLMLAEYCNAHETARAARSAASLMKRQVNEFREALHKTSLEIVQMEWmhdatltpsynsritfqkyfssdddiypiilnlsrpkLLETLQSSVTKIARSVESLQACERSSLTAEGQLERamgwacggpnssaagnsstktsgippefhDHLMRRRQLLWEAREKASKIVNICMSVLdfeasrdgvfrtpgevyparvgvdARSWQQVYLNAVTKLEVAYHSFTCAEQEWKLAQSSMEAASNGLYSATNELCIASLKAksasgdlqstvlTMRDCAYEASAALTAFGRVSRVHtaltsesgsMLEEVLAITEDLHDVHSLGKEAAAINHSLMEDLSKANAVLLPLDSVLSKDVAAMSDAITSEretkmevspihgqAIYQSYCLRVRDACQLLKPLLPSLMSSVKGLYSMLTRLARTASLHAGNLHKALEglgesqevksqgvslsrsdltaadssqfdekgreafsgsdsgsikddflgvsgislqdkgwisppdsiyssssesaitsgeaslpdssnnpveltgqhphglnqdsgqsvskrtevnntdsgsvkftvdepieyfkaqesptgeaVSVAVgssqplgnnsevkfgvKDEVSSVNkvgieeennedhvpnthtvsrvargkNAYAISVLRRVEMKLDGRDIVENRNLSIAEQVDHLLKQATSVDNLCNmyegwtpwi
mlaklspwcivyPTLVDVNAYEERPSEELQHILGCLRELYPRLIQDVELMINELGNLTVLWEELWLSTLQDLHADVMRRINVLKEEAARiaenatlsqsekkKINAAKYSAMMAPIVVALERRLASTSRKPETPHEIWFHEEFGEQLKSAILNFKTPPASAAALGDVWRPFDNIAASLASHQRKSSVSLSEVAPQLSLLSSSDVPMPGFEKQVAtsesdgglTATLRGIVTIASFSEEVSILSTKTKPKKLVILGQMLLQAVNSFLRSSPATRSHSLGIRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQFSAIGAGNAKSSVPPPVPRPSDMFYGKIIpalkekgirrvisrrdwphdvKRKVLLDLMKEVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIEWTRGDFHDDAAIGGEERKGMELAVSLSLFASRVQEIRVPLQEHHDLLLATLPAVELALERFADVLSQYELASALFYRADQERSNLVLHETSTKSMVAEANCNAEKIRASFEVQAREFAQAKAVVTEKAQEATTWMEQHGRILDALRGNLIPEINSCIKLSGSMDAFSLTSAVLVAGVPFSIVPEPTQVQCHDIDKDVSQLIAELDHGLSSVFIALQAYSLALQRILPLNYLTTTAVHGWAQVLQLSANAPSVDILSLARRQATELIVRIhgdnhdsikqnhddlRLKVEKYGVEIEKVEKECAELvnsigseteskaKDRFLLAFMKYMKSAGlvrkedvsssyqsgqlkndgrkdaglrgkqdenkeklLSVLNVAVTHLYDEVKCRVLDIFSdsaggikgnnrMQLDFGTLFCEFDEQVEKCILVAGFVNELWQSIGRDMYDNDADIECPNYHFERNWASIFKTSLLACKTLVGQMTEVVLPDVMRSTISFNSEVMDAFGLVSQIRGSIDTTLEQLVEVELERASLVELEQSYFVKVGLITEQQLALEEAAVKGRDHLSWEEAEELASQEEACKAELNELHQTWNQRDMRSSSLMKQEADIRNALVSSERHFQSVisaeefrephiLRSKALLAILVKPFMELESVDKTLASFCESVGSIPYGTPKLADLINSGRSISECIWNFGSLSNGHSFFIWKMGIIDSFLDSCVHDVAASVDQNLGFDQLFNVVKKKLEVQLQEHVGLYLKERVAPIILAFLDKEIEHLKKLTestkeltaddakkdtGAVRRVQLMLAEYCNAHETARAARSAASLMKRQVNEFREALHKTSLEIVQMEWMHDATLTPSYNSRITFQKYFSSDDDIYPIILNLSRPKLLETLQSSVTKIARSVESLQACERSSLTAEGQLERAMGWACGGPNSSAAGNSSTKTSGIPPEFHDHLMRRRQLLWEAREKASKIVNICMSVLDFEASRDGVFRTPGEVYPARVGVDARSWQQVYLNAVTKLEVAYHSFTCAEQEWKLAQSSMEAASNGLYSATNELCIASLKAKSASGDLQSTVLTMRDCAYEASAALTAFGRVSRVHTALTSESGSMLEEVLAITEDLHDVHSLGKEAAAINHSLMEDLSKANAVLLPLDSVLSKDVAAMSDAITSeretkmevspiHGQAIYQSYCLRVRDACQLLKPLLPSLMSSVKGLYSMLTRLARTASLHAGNLHKALEGLGESQEVKSQGvslsrsdltaadssqfdekgreafsgsdsgsiKDDFLGVSGISLQDKGWISPPDSIYSSSSESAITSGEASLPDSSNNPVELTGQHPhglnqdsgqsvskrtevnntdsgsvkftVDEPIEYFKAQESPTGEAVSVAVGSsqplgnnsevkfgvkDEVSSVNKVgieeennedhvpnthtvsrvargknayAISVLRRVEMKLDGRDIVENRNLSIAEQVDHLLKQATSVDNLCNMYEGWTPWI
MLAKLSPWCIVYPTLVDVNAYEERPSEELQHILGCLRELYPRLIQDVELMINELGNLTVLWEELWLSTLQDLHADVMRRINVLKEEAARIAENATLSQSEKKKINAAKYSAMMAPIVVALERRLASTSRKPETPHEIWFHEEFGEQLKSAILNFKTPPASAAALGDVWRPFDNIAASLASHQRKSSVSLSEVAPQLSLLSSSDVPMPGFEKQVATSESDGGLTATLRGIVTIASFSEEVSILSTKTKPKKLVILGQMLLQAVNSFLRSSPATRSHSLGIRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQFSAIGAGNAKssvpppvprpsDMFYGKIIPALKEKGIRRVISRRDWPHDVKRKVLLDLMKEVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIEWTRGDFHDDAAIGGEERKGMELAVSLSLFASRVQEIRVPLQEHHDLLLATLPAVELALERFADVLSQYELASALFYRADQERSNLVLHETSTKSMVAEANCNAEKIRASFEVQAREFAQAKAVVTEKAQEATTWMEQHGRILDALRGNLIPEINSCIKLSGSMDAFSLTSAVLVAGVPFSIVPEPTQVQCHDIDKDVSQLIAELDHGLSSVFIALQAYSLALQRILPLNYLTTTAVHGWAQVLQLSANAPSVDILSLARRQATELIVRIHGDNHDSIKQNHDDLRLKVEKYGVEIEKVEKECAELVNSIGSETESKAKDRFLLAFMKYMKSAGLVRKEDVSSSYQSGQLKNDGRKDAGLRGKQDENKEKLLSVLNVAVTHLYDEVKCRVLDIFSDSAGGIKGNNRMQLDFGTLFCEFDEQVEKCILVAGFVNELWQSIGRDMYDNDADIECPNYHFERNWASIFKTSLLACKTLVGQMTEVVLPDVMRSTISFNSEVMDAFGLVSQIRGSIDTTleqlveveleRASLVELEQSYFVKVGLITEQQLALEEAAVKGRDHLSWeeaeelasqeeaCKAELNELHQTWNQRDMRSSSLMKQEADIRNALVSSERHFQSVISAEEFREPHILRSKALLAILVKPFMELESVDKTLASFCESVGSIPYGTPKLADLINSGRSISECIWNFGSLSNGHSFFIWKMGIIDSFLDSCVHDVAASVDQNLGFDQLFNVVKKKLEVQLQEHVGLYLKERVAPIILAFLDKEIEHLKKLTESTKELTADDAKKDTGAVRRVQLMLAEYCNAHETaraarsaasLMKRQVNEFREALHKTSLEIVQMEWMHDATLTPSYNSRITFQKYFSSDDDIYPIILNLSRPKLLETLQSSVTKIARSVESLQACERSSLTAEGQLERAMGWACggpnssaagnssTKTSGIPPEFHDHLMRRRQLLWEAREKASKIVNICMSVLDFEASRDGVFRTPGEVYPARVGVDARSWQQVYLNAVTKLEVAYHSFTCAEQEWKLAQSSMEAASNGLYSATNELCIASLKAKSASGDLQSTVLTMRDCAYEASAALTAFGRVSRVHTALTSESGSMLEEVLAITEDLHDVHSLGKEAAAINHSLMEDLSKANAVLLPLDSVLSKDVAAMSDAITSERETKMEVSPIHGQAIYQSYCLRVRDACQllkpllpslmssVKGLYSMLTRLARTASLHAGNLHKALEGLGESQEVKSQGVSLSRSDLTAADSSQFDEKGREAFSGSDSGSIKDDFLGVSGISLQDKGWIsppdsiyssssesaitsgeasLPDSSNNPVELTGQHPHGLNQDSGQSVSKRTEVNNTDSGSVKFTVDEPIEYFKAQESPTGEAVSVAVGSSQPLGNNSEVKFGVKDEVSSVNKVGIEEENNEDHVPNTHTVSRVARGKNAYAISVLRRVEMKLDGRDIVENRNLSIAEQVDHLLKQATSVDNLCNMYEGWTPWI
****LSPWCIVYPTLVDVNAYEERPSEELQHILGCLRELYPRLIQDVELMINELGNLTVLWEELWLSTLQDLHADVMRRINVLKEEAARI****************AKYSAMMAPIVVALER************HEIWFHEEFGEQLKSAILNFKTPPASAAALGDVWRPFDNIAA*********************************************LTATLRGIVTIASFSEEVSILSTKTKPKKLVILGQMLLQAVNSFLRSSPATRSHSLGIRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQFSAIG*****************MFYGKIIPALKEKGIRRVISRRDWPHDVKRKVLLDLMKEVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIEWTRGDFHDDAAIGGEERKGMELAVSLSLFASRVQEIRVPLQEHHDLLLATLPAVELALERFADVLSQYELASALFYRADQERSNLVLHE*****MVAEANCNAEKIRASFEVQAREFAQAKAVVTEKAQEATTWMEQHGRILDALRGNLIPEINSCIKLSGSMDAFSLTSAVLVAGVPFSIVPEPTQVQCHDIDKDVSQLIAELDHGLSSVFIALQAYSLALQRILPLNYLTTTAVHGWAQVLQLSANAPSVDILSLARRQATELIVRIHGDNHDSIKQNHDDLRLKVEKYGVEIEKVEKECAELVNSI*********DRFLLAFMKYMKSAGL***********************************LLSVLNVAVTHLYDEVKCRVLDIFSDSAGGIKGNNRMQLDFGTLFCEFDEQVEKCILVAGFVNELWQSIGRDMYDNDADIECPNYHFERNWASIFKTSLLACKTLVGQMTEVVLPDVMRSTISFNSEVMDAFGLVSQIRGSIDTTLEQLVEVELERASLVELEQSYFVKVGLITEQQLALEEAAVKG**********************************************************QSVISAEEFREPHILRSKALLAILVKPFMELESVDKTLASFCESVGSIPYGTPKLADLINSGRSISECIWNFGSLSNGHSFFIWKMGIIDSFLDSCVHDVAASVDQNLGFDQLFNVVKKKLEVQLQEHVGLYLKERVAPIILAFLDKEIEHLKKL*****************AVRRVQLMLAEYCNAHETA************QVNEFREALHKTSLEIVQMEWMHDATLTPSYNSRITFQKYFSSDDDIYPIILNLSRPKLLETLQSSVTKI******************************************************LMRRRQLLWEAREKASKIVNICMSVLDFEASRDGVFRTPGEVYPARVGVDARSWQQVYLNAVTKLEVAYHSFTCAEQEWKLAQS***AASNGLYSATNELCIASLKAKSASGDLQSTVLTMRDCAYEASAALTAFGRVSRVHTALTSESGSMLEEVLAITEDLHDVHSLGKEAAAINHSLMEDLSKANAVLLPLDSVLSKDV****************VSPIHGQAIYQSYCLRVRDACQLLKPLLPSLMSSVKGLYSMLTRLARTASLHAGNL****************************************************FLGVSGISL****W*************************************************************************************************************************************RVARGKNAYAISVLRRVEMKLDGRDIVENRNLSIAEQVDHLLKQATSVDNLCNMYEGWTPW*
MLAKLSPWCIVYPTLV*****************GCLRELYPRLIQDVELMINELGNLTVLWEELWLSTLQDLHADVMRRINVLKEEAARIAENATLSQSEKKKINAAKYSAMMAPIVVALERR*********TPHEIWFHEEFGEQLKSAILNFKTPPAS*AALGDVWRPFDNIA*****************APQLSLLSSSDVPMPGFEKQVATSESD**LTATLRGIVTIASFSEEVSILSTKTKPKKLVILGQMLLQAVNSFLRSSPATRSHSLGIRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQ**************PPVPRPSDMFYGKIIPALKEKGIRRVISRRDWPHDVKRKVLLDLMKEVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIE*******************************************************LALERFADVLSQYELASALFYRADQERSN**************************************VVTEKAQEATTWMEQHGRILDALRGNLIPEINSCIKLSGSMDAFSLTSAVLVAGVPFSIVPEPTQVQCHDIDKDVSQLIAELDHGLSSVFIALQAYSLALQRILPLNYLTTTAVHGWAQVLQLSANAPSVDILSLARRQATELI***********KQNHDDLRLKVEKYGVEIEKV*****************KAKDRFLLAFMK************************DGRKDAGLRGKQDENKEKLLSVLNVAVTHLYDEVKCRVLDIFS**AGGIKGNNRMQLDFGTLFCEFDEQVEKCILVAGFVNELWQSIGRDMY*********NYHFERNWASIFKTSLLACKTLVGQMTEVVLPDVMRSTISFNSEVMDAFGLVSQIRGSIDTTLEQLVEVELERASLVELEQSYFVKVGLITEQQLALE**********************EACKAELNELHQTWNQRDMRSSSLMKQEADIRNALVSSERHFQS***********ILRSKALLAILVKPFMELESVDKTLASFCESVGSIPYGTPKLAD*****RSISECIWNFGSLSNGHSFFIWKMGIIDSFLDSCVHDVAASVDQNLGFDQLFNVVKKKLEVQLQEHVGLYLKERVAPIILAFLDKEIEHLKK******************AVRRVQLMLAEYCNAHETARAARSAASLMKRQVNEFREALHKTSLEIVQMEWMHDATLTPSYN*************DIYPIILNLSRPKLLETLQSSVT**************************MGWACGGP***************PPEFHDHLMRRRQ*****REKASKIVNICMSVLDFEASRDGVFR***************SWQQVYLNAVTKLEVAYHSFTCAEQEWKLAQSSMEAASNGLYSATNE******************VLTMRDCAYEASAALTAFGRVSR**TALTSESGSMLEEVLAITEDLHDVHSLGKEAAAINHSLMEDLSKANAVLLPLDSVLSKDVAAMSD*****************QAIYQSYCLRVRDACQLLKPLLPSLMSSVKGLYSMLTRLAR**SL***********************************************************GVSGISLQD**************************************************************************************************************************************************ISVLRRVEMKLDGRDIVENRNLSIAEQVDHLLKQATSVDNLCNMYEGWTPWI
MLAKLSPWCIVYPTLVDVNAYEERPSEELQHILGCLRELYPRLIQDVELMINELGNLTVLWEELWLSTLQDLHADVMRRINVLKEEAARIAENATLSQSEKKKINAAKYSAMMAPIVVALERR*********TPHEIWFHEEFGEQLKSAILNFKTPPASAAALGDVWRPFDNIAASL***************PQLSLLSSSDVPMPGFEK********GGLTATLRGIVTIASFSEEVSILSTKTKPKKLVILGQMLLQAVNSFLRSSPATRSHSLGIRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQFSAIGAGNAKSSVPPPVPRPSDMFYGKIIPALKEKGIRRVISRRDWPHDVKRKVLLDLMKEVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIEWTRGDFHDDAAIGGEERKGMELAVSLSLFASRVQEIRVPLQEHHDLLLATLPAVELALERFADVLSQYELASALFYRADQERSNLVLHETSTKSMVAEANCNAEKIRASFEVQAREFAQAKAVVTEKAQEATTWMEQHGRILDALRGNLIPEINSCIKLSGSMDAFSLTSAVLVAGVPFSIVPEPTQVQCHDIDKDVSQLIAELDHGLSSVFIALQAYSLALQRILPLNYLTTTAVHGWAQVLQLSANAPSVDILSLARRQATELIVRIHGDNHDSIKQNHDDLRLKVEKYGVEIEKVEKECAELVNSIGSETESKAKDRFLLAFMKYMKSAG***********************AGLRGKQDENKEKLLSVLNVAVTHLYDEVKCRVLDIFSDSAGGIKGNNRMQLDFGTLFCEFDEQVEKCILVAGFVNELWQSIGRDMYDNDADIECPNYHFERNWASIFKTSLLACKTLVGQMTEVVLPDVMRSTISFNSEVMDAFGLVSQIRGSIDTTLEQLVEVELERASLVELEQSYFVKVGLITEQQLALEEAAVKGRDHLSW*********EEACKAELNELHQTWNQRDMRSSSLMKQEADIRNALVSSERHFQSVISAEEFREPHILRSKALLAILVKPFMELESVDKTLASFCESVGSIPYGTPKLADLINSGRSISECIWNFGSLSNGHSFFIWKMGIIDSFLDSCVHDVAASVDQNLGFDQLFNVVKKKLEVQLQEHVGLYLKERVAPIILAFLDKEIEHLKKLTESTKELTADDAKKDTGAVRRVQLMLAEYCNAHETARAARSAASLMKRQVNEFREALHKTSLEIVQMEWMHDATLTPSYNSRITFQKYFSSDDDIYPIILNLSRPKLLETLQSSVTKIARSVESLQACERSSLTAEGQLERAMGWACGG*************SGIPPEFHDHLMRRRQLLWEAREKASKIVNICMSVLDFEASRDGVFRTPGEVYPARVGVDARSWQQVYLNAVTKLEVAYHSFTCAEQEWKLAQSSMEAASNGLYSATNELCIASLKAKSASGDLQSTVLTMRDCAYEASAALTAFGRVSRVHTALTSESGSMLEEVLAITEDLHDVHSLGKEAAAINHSLMEDLSKANAVLLPLDSVLSKDVAAMSDAITSERETKMEVSPIHGQAIYQSYCLRVRDACQLLKPLLPSLMSSVKGLYSMLTRLARTASLHAGNLHKALEGLG*************************************SGSIKDDFLGVSGISLQDKGWISPPD***********************NPVELTGQHPH*****************NTDSGSVKFTVDEPIEYFKAQE***********GSSQPLGNNSEVKFGVKDEVSSVNKVGIEEENNEDHVPNTHTVSRVARGKNAYAISVLRRVEMKLDGRDIVENRNLSIAEQVDHLLKQATSVDNLCNMYEGWTPWI
**AKLSPWCIVYPTLVDVNAYEERPSEELQHILGCLRELYPRLIQDVELMINELGNLTVLWEELWLSTLQDLHADVMRRINVLKEEAARIAENATLSQSEKKKINAAKYSAMMAPIVVALERRLASTSRKPETPHEIWFHEEFGEQLKSAILNFKTPPASAAALGDVWRPFDNIAASLASHQRKSSVSLSEVAPQLSLLSSSDVPMPGFEK*************TLRGIVTIASFSEEVSILSTKTKPKKLVILGQMLLQAVNSFLRSSPATRSHSLGIRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQFSAIGAGNAKSSVPPPVPRPSDMFYGKIIPALKEKGIRRVISRRDWPHDVKRKVLLDLMKEVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIEWTRGD************************ASRVQEIRVPLQEHHDLLLATLPAVELALERFADVLSQYELASALFYRADQERSNLVLHETSTKSMVAEANCNAEKIRASFEVQAREFAQAKAVVTEKAQEATTWMEQHGRILDALRGNLIPEINSCIKLSGSMDAFSLTSAVLVAGVPFSIVPEPTQVQCHDIDKDVSQLIAELDHGLSSVFIALQAYSLALQRILPLNYLTTTAVHGWAQVLQLSANAPSVDILSLARRQATELIVRIHGDNHDSIKQNHDDLRLKVEKYGVEIEKVEKECAELVNSIGSETESKAKDRFLLAFMKYMKSAGLV******SS**S**LKNDGRKDAGLRGKQDENKEKLLSVLNVAVTHLYDEVKCRVLDIFSDSAGGIKGNNRMQLDFGTLFCEFDEQVEKCILVAGFVNELWQSIGRDMYDNDADIECPNYHFERNWASIFKTSLLACKTLVGQMTEVVLPDVMRSTISFNSEVMDAFGLVSQIRGSIDTTLEQLVEVELERASLVELEQSYFVKVGLITEQQLALEEAAVKGRDHLSWEEAEELASQEEACKAELNELHQTWNQRDMRSSSLMKQEADIRNALVSSERHFQSVISAEEFREPHILRSKALLAILVKPFMELESVDKTLASFCESVGSIPYGTPKLADLINSGRSISECIWNFGSLSNGHSFFIWKMGIIDSFLDSCVHDVAASVDQNLGFDQLFNVVKKKLEVQLQEHVGLYLKERVAPIILAFLDKEIEHLKKLTESTKELTADDAKKDTGAVRRVQLMLAEYCNAHETARAARSAASLMKRQVNEFREALHKTSLEIVQMEWMHDATLTPSYNSRITFQKYFSSDDDIYPIILNLSRPKLLETLQSSVTKIARSVESLQACERSSLTAEGQLERAMGWACGG**************GIPPEFHDHLMRRRQLLWEAREKASKIVNICMSVLDFEASRDGVFRTPG*******GVDARSWQQVYLNAVTKLEVAYHSFTCAEQEWKLAQSSMEAASNGLYSATNELCIASLKAKSASGDLQSTVLTMRDCAYEASAALTAFGRVSRVHTALTSESGSMLEEVLAITEDLHDVHSLGKEAAAINHSLMEDLSKANAVLLPLDSVLSKDVAAMSDAITSERETKMEVSPIHGQAIYQSYCLRVRDACQLLKPLLPSLMSSVKGLYSMLTRLARTASLHAGNLHKALEGL******************************************KDDFLGVSGISLQDKGWISPPDSIYSS************LP**********************************DSGSVKFTVDEPIEYFKAQESPTGEAVS******************************************THTVSRVARGKNAYAISVLRRVEMKLDGRDIVENRNLSIAEQVDHLLKQATSVDNLCNMYEGWTPWI
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MLAKLSPWCIVYPTLVDVNAYEERPSEELQHILGCLRELYPRLIQDVELMINELGNLTVLWEELWxxxxxxxxxxxxxxxxxxxxxAARIAENATLSQSEKKKINAAKYSAMMAPIVVALERRLASTSRKPETPHEIWFHEEFGEQLKSAILNFKTPPASAAALGDVWRPFDNIAASLASHQRKSSVSLSEVAPQLSLLSSSDVPMPGFEKQVATSESDGGLTATLRGIVTIASFSEEVSILSTKTKPKKLVILGQMLLQAVNSFLRSSPATRSHSLGIRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQFSAIGAGNAKSSVPPPVPRPSDMFYGKIIPALKEKGIRRVISRRDWPHDVKRKVLLDLMKEVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIEWTRGDFHDDAAIGGEERKGMELAVSLSLFASRVQEIRVPLQEHHDLLLATLPAVELALERFADVLSQYELASALFYRADQERSNLVLHETSTKSMVAEANCNAEKIRASFEVQAREFAQAKAVVTEKAQEATTWMEQHGRILDALRGNLIPEINSCIKLSGSMDAFSLTSAVLVAGVPFSIVPEPTQVQCHDIDKDVSQLIAELDHGLSSVFIALQAYSLALQRILPLNYLTTTAVHGWAQVLQLSANAPSVDILSLARRQATELIVRIHGDNHDSIKQNxxxxxxxxxxxxxxxxxxxxxxxxxxxxIGSETESKAKDRFLLAFMKYMKSAGLVRKEDVSSSYQSGQLKNDGRKDAGLRGKQDENKEKLLSVLNVAVTHLYDEVKCRVLDIFSDSAGGIKGNNRMQLDFGTLFCEFDEQVEKCILVAGFVNELWQSIGRDMYDNDADIECPNYHFERNWASIFKTSLLACKTLVGQMTEVVLPDVMRSTISFNSEVMDAFGLVSQIRGSIDTTLEQLVEVELERASLVELEQSYFVKVGLITEQQLALEEAAVKGRDHLSWEExxxxxxxxxxxxxxxxxxxxxWNQRDMRSSSLMKQEADIRNALVSSERHFQSVISAEEFREPHILRSKALLAILVKPFMELESVDKTLASFCESVGSIPYGTPKLADLINSGRSISECIWNFGSLSNGHSFFIWKMGIIDSFLDSCVHDVAASVDQNLGFDQLFNVVKKKLEVQLQEHVGLYLKERVAPIILAFLDKEIEHLKKLTESTKELTADDAKKDTGAVRRVQLMLAEYCNAHETARAARSAASLMKRQVNEFREALHKTSLEIVQMEWMHDATLTPSYNSRITFQKYFSSDDDIYPIILNLSRPKLLETLQSSVTKIARSVESLQACERSSLTAEGQLERAMGWACGGPNSSAAGNSSTKTSGIPPEFHDHLMRRRQLLWEAREKASKIVNICMSVLDFEASRDGVFRTPGEVYPARVGVDARSWQQVYLNAVTKLEVAYHSFTCAEQEWKLAQSSMEAASNGLYSATNELCIASLKAKSASGDLQSTVLTMRDCAYEASAALTAFGRVSRVHTALTSESGSMLEEVLAITEDLHDVHSLGKEAAAINHSLMEDLSKANAVLLPLDSVLSKDVAAMSDAITSERETKMEVSPIHGQAIYQSYCLRVRDACQLLKPLLPSLMSSVKGLYSMLTRLARTASLHAGNLHKALEGLGESQEVKSQGVSLSRSDLTAADSSQFDEKGREAFSGSDSGSIKDDFLGVSGISLQDKGWISPPDSIYSSSSESAITSGEASLPDSSNNPVELTGQHPHGLNQDSGQSVSKRTEVNNTDSGSVKFTVDEPIEYFKAQESPTGEAVSVAVGSSQPLGNNSEVKFGVKDEVSSVNKVGIEEENNEDHVPNTHTVSRVARGKNAYAISVLRRVEMKLDGRDIVENRNLSIAEQVDHLLKQATSVDNLCNMYEGWTPWI
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query1989 2.2.26 [Sep-21-2011]
Q8BKX63658 Serine/threonine-protein yes no 0.261 0.142 0.389 1e-116
Q96Q153661 Serine/threonine-protein yes no 0.261 0.142 0.389 1e-116
Q70PP23218 Serine/threonine-protein yes no 0.243 0.150 0.326 1e-79
Q553E92344 Probable serine/threonine yes no 0.231 0.196 0.326 3e-77
Q61CW22313 Serine/threonine-protein N/A no 0.250 0.215 0.315 1e-75
O015102322 Serine/threonine-protein yes no 0.247 0.212 0.311 4e-73
P326002474 Serine/threonine-protein yes no 0.228 0.183 0.276 1e-44
Q9FR532481 Serine/threonine-protein yes no 0.221 0.177 0.285 3e-44
Q86C652380 Target of rapamycin OS=Di no no 0.218 0.182 0.277 2e-43
Q0DJS12465 Serine/threonine-protein no no 0.222 0.179 0.275 2e-43
>sp|Q8BKX6|SMG1_MOUSE Serine/threonine-protein kinase SMG1 OS=Mus musculus GN=Smg1 PE=1 SV=3 Back     alignment and function desciption
 Score =  422 bits (1084), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 226/580 (38%), Positives = 337/580 (58%), Gaps = 60/580 (10%)

Query: 41   PRLIQDVELMINELGNLTVLWEELWLSTLQDLHADVMRRINVLKEEAARIAENATLSQSE 100
            P ++  V++++ EL  +TVLW+ELWL  L   H  V+RRI  L++E  R+  N TL + E
Sbjct: 1940 PTMVLQVQMLVAELRRVTVLWDELWLGVLLQQHMYVLRRIQQLEDEVKRVQNNNTLRKEE 1999

Query: 101  KKKINAAKYSAMMAPIVVALERRLASTSRKPETPHEIWFHEEFGEQLKSAILNFKTPPAS 160
            K  I   K++A+M PIV ALE   + T+   ETPHE WF + +G+ + +A+   KTP ++
Sbjct: 2000 KIAIMREKHTALMKPIVFALEHVRSITAAPAETPHEKWFQDNYGDAIDNALEKLKTP-SN 2058

Query: 161  AAALGDVWRPFDNIAASLASHQRKSS---VSLSEVAPQLSLLSSSDVPMPGFEKQVATSE 217
             A  G  W PF  I  SL    +K +   + L E++P L+ ++++++ +PG         
Sbjct: 2059 PAKPGSSWIPFKEIMLSLQQRAQKRASYILRLDEISPWLAAMTNTEIALPG--------- 2109

Query: 218  SDGGLTATLRGIVTIASFSEEVSILSTKTKPKKLVILG---------------------- 255
                   + R  VTI S    ++IL TKTKPKKL+ LG                      
Sbjct: 2110 -----EVSARDTVTIHSVGGTITILPTKTKPKKLLFLGSDGKSYPYLFKGLEDLHLDERI 2164

Query: 256  QMLLQAVNSFLRSSPATRSHSLGIRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQ 315
               L  VN+   +     +     R+YSVTP+  R+GLIQWVD    ++ ++K WQ R  
Sbjct: 2165 MQFLSIVNTMFATINRQETPRFHARHYSVTPLGTRSGLIQWVDGATPLFGLYKRWQQRE- 2223

Query: 316  LAQFSAIGAGNAKSSVPPP-----VPRPSDMFYGKIIPALKEKGIRRVISRRDWPHDVKR 370
                +A+ A  A+ S   P     VPRPS+++Y KI PALK  G+   +SRRDWP  V +
Sbjct: 2224 ----AALQAQKAQDSYQTPQNPSIVPRPSELYYSKIGPALKTVGLSLDVSRRDWPLHVMK 2279

Query: 371  KVLLDLMKEVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNI 430
             VL +LM+  P  LL +E+W +      +    + Y+ S A MSMVG+I+GLGDRHLDN+
Sbjct: 2280 AVLEELMEATPPNLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNV 2339

Query: 431  LLDFSSGDIVHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVS 490
            L+D ++G++VHIDYNVCF+KG+ L+VPE VPFR+TQ IE ALG+TG+EG FR +CE V+ 
Sbjct: 2340 LIDMTTGEVVHIDYNVCFEKGKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLH 2399

Query: 491  VLRKNKDILLMLLEVFVWDPLIEWTRGDFHDDAAI----GGEE------RKGMELAVSLS 540
            ++R+ ++ LL LLE FV+DPL++WT G     A      GG++      ++ ME  ++ S
Sbjct: 2400 IMRRGRETLLTLLEAFVYDPLVDWTAGGEAGFAGAVYGGGGQQAESKQSKREMEREITRS 2459

Query: 541  LFASRVQEIRVPLQEHHDLLLATLPAVELALERFADVLSQ 580
            LF+SRV EI+V   ++ D +L  LP ++ +L+ +  +  Q
Sbjct: 2460 LFSSRVAEIKVNWFKNRDEMLVVLPKLDSSLDEYLSLQEQ 2499




Serine/threonine protein kinase involved in both mRNA surveillance and genotoxic stress response pathways. Recognizes the substrate consensus sequence [ST]-Q. Plays a central role in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons by phosphorylating UPF1/RENT1. Recruited by release factors to stalled ribosomes together with SMG8 and SMG9 (forming the SMG1C protein kinase complex), and UPF1 to form the transient SURF (SMG1-UPF1-eRF1-eRF3) complex. In EJC-dependent NMD, the SURF complex associates with the exon junction complex (EJC) through UPF2 and allows the formation of an UPF1-UPF2-UPF3 surveillance complex which is believed to activate NMD. Also acts as a genotoxic stress-activated protein kinase that displays some functional overlap with ATM. Can phosphorylate p53/TP53 and is required for optimal p53/TP53 activation after cellular exposure to genotoxic stress. Its depletion leads to spontaneous DNA damage and increased sensitivity to ionizing radiation (IR). May activate PRKCI but not PRKCZ.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1
>sp|Q96Q15|SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 Back     alignment and function description
>sp|Q70PP2|SMG1_DROME Serine/threonine-protein kinase Smg1 OS=Drosophila melanogaster GN=Smg1 PE=1 SV=2 Back     alignment and function description
>sp|Q553E9|SMG1_DICDI Probable serine/threonine-protein kinase smg1 OS=Dictyostelium discoideum GN=smg1 PE=3 SV=1 Back     alignment and function description
>sp|Q61CW2|SMG1_CAEBR Serine/threonine-protein kinase smg-1 OS=Caenorhabditis briggsae GN=smg-1 PE=3 SV=3 Back     alignment and function description
>sp|O01510|SMG1_CAEEL Serine/threonine-protein kinase smg-1 OS=Caenorhabditis elegans GN=smg-1 PE=1 SV=3 Back     alignment and function description
>sp|P32600|TOR2_YEAST Serine/threonine-protein kinase TOR2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=TOR2 PE=1 SV=3 Back     alignment and function description
>sp|Q9FR53|TOR_ARATH Serine/threonine-protein kinase TOR OS=Arabidopsis thaliana GN=TOR PE=1 SV=1 Back     alignment and function description
>sp|Q86C65|TOR_DICDI Target of rapamycin OS=Dictyostelium discoideum GN=tor PE=1 SV=1 Back     alignment and function description
>sp|Q0DJS1|TOR_ORYSJ Serine/threonine-protein kinase TOR OS=Oryza sativa subsp. japonica GN=TOR PE=2 SV=3 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query1989
359475153 3787 PREDICTED: serine/threonine-protein kina 0.992 0.521 0.752 0.0
255556185 3804 conserved hypothetical protein [Ricinus 0.981 0.513 0.720 0.0
297741391 3305 unnamed protein product [Vitis vinifera] 0.906 0.545 0.703 0.0
356541123 3720 PREDICTED: serine/threonine-protein kina 0.976 0.522 0.685 0.0
357473157 3764 Serine/threonine protein kinase atr [Med 0.957 0.506 0.683 0.0
449455326 3931 PREDICTED: uncharacterized protein LOC10 0.992 0.502 0.651 0.0
449511923 3865 PREDICTED: uncharacterized LOC101222679 0.971 0.500 0.634 0.0
297832098 3792 hypothetical protein ARALYDRAFT_899833 [ 0.985 0.516 0.612 0.0
297601656 3476 Os03g0738100 [Oryza sativa Japonica Grou 0.862 0.493 0.552 0.0
31126780 3454 putative phosphatidylinositol 3-kinase-r 0.849 0.488 0.545 0.0
>gi|359475153|ref|XP_002281272.2| PREDICTED: serine/threonine-protein kinase SMG1 [Vitis vinifera] Back     alignment and taxonomy information
 Score = 3031 bits (7859), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 1530/2033 (75%), Positives = 1731/2033 (85%), Gaps = 58/2033 (2%)

Query: 1    MLAKLSPWCIVYPTLVDVNAYEERPSEELQHILGCLRELYPRLIQDVELMINELGNLTVL 60
            MLAKLSPW IVYPTLVDVNAYEE PSEELQH++GCL +LYPRLIQDV+LMINEL N+TVL
Sbjct: 1769 MLAKLSPWSIVYPTLVDVNAYEEEPSEELQHVVGCLSKLYPRLIQDVQLMINELENVTVL 1828

Query: 61   WEELWLSTLQDLHADVMRRINVLKEEAARIAENATLSQSEKKKINAAKYSAMMAPIVVAL 120
            WEELWLSTLQDLH+DVMRRIN+LKEEAARIAEN TLSQ EK KINAAKYSAMMAP+VVAL
Sbjct: 1829 WEELWLSTLQDLHSDVMRRINLLKEEAARIAENVTLSQGEKNKINAAKYSAMMAPVVVAL 1888

Query: 121  ERRLASTSRKPETPHEIWFHEEFGEQLKSAILNFKTPPASAAALGDVWRPFDNIAASLAS 180
            ERRLASTSRKPETPHEIWFHEE+ EQLKSAIL FKTPPAS+AALGDVWRPFDNIAASL+S
Sbjct: 1889 ERRLASTSRKPETPHEIWFHEEYREQLKSAILTFKTPPASSAALGDVWRPFDNIAASLSS 1948

Query: 181  HQRKSSVSLSEVAPQLSLLSSSDVPMPGFEKQVATSESDGGLTATLRGIVTIASFSEEVS 240
            +QRKSS+SL EVAPQL+LLSSSDVPMPG E+Q+  SESD GLTATL+GIVTIASFSE+V+
Sbjct: 1949 YQRKSSISLGEVAPQLALLSSSDVPMPGLERQIIASESDRGLTATLQGIVTIASFSEQVA 2008

Query: 241  ILSTKTKPKKLVILG----------------------QMLLQAVNSFLRSSPATRSHSLG 278
            ILSTKTKPKK+VILG                        LLQA N FLRSSP TRSHSL 
Sbjct: 2009 ILSTKTKPKKIVILGSDGHKYTYLLKGREDLRLDARIMQLLQAFNGFLRSSPETRSHSLV 2068

Query: 279  IRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQFSAIGAGNAKSSVPPPVPRP 338
            IRYYSVTPISGRAGLIQWVDNVISIYS+FKSWQ+RAQLA  S++GAGN K+SVPPPVPRP
Sbjct: 2069 IRYYSVTPISGRAGLIQWVDNVISIYSIFKSWQNRAQLAHLSSLGAGNTKNSVPPPVPRP 2128

Query: 339  SDMFYGKIIPALKEKGIRRVISRRDWPHDVKRKVLLDLMKEVPRQLLHQEIWCASEGFKA 398
            SDMFYGKIIPALKEKGIRRVISRRDWPH+VKRKVLLDLMKE PRQLLHQE+WCASEGFKA
Sbjct: 2129 SDMFYGKIIPALKEKGIRRVISRRDWPHEVKRKVLLDLMKEAPRQLLHQELWCASEGFKA 2188

Query: 399  FSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFDKGQRLKVPE 458
            FSLKLKRYS SVAAMSMVGHILGLGDRHLDNIL+DF +GDIVHIDYNVCFDKGQRLK+PE
Sbjct: 2189 FSLKLKRYSGSVAAMSMVGHILGLGDRHLDNILMDFFTGDIVHIDYNVCFDKGQRLKIPE 2248

Query: 459  IVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIEWTRGD 518
            IVPFRLTQ IE ALGLTGIEGTFRANCEAVV VLRKNKDILLMLLEVFVWDPL+EWTRGD
Sbjct: 2249 IVPFRLTQMIETALGLTGIEGTFRANCEAVVGVLRKNKDILLMLLEVFVWDPLVEWTRGD 2308

Query: 519  FHDDAAIGGEERKGMELAVSLSLFASRVQEIRVPLQEHHDLLLATLPAVELALERFADVL 578
            FHDDAAIGGEERKGMELAVSLSLFASRVQEIRVPLQEHHDLLLATLPAVE ALERF+D+L
Sbjct: 2309 FHDDAAIGGEERKGMELAVSLSLFASRVQEIRVPLQEHHDLLLATLPAVESALERFSDIL 2368

Query: 579  SQYELASALFYRADQERSNLVLHETSTKSMVAEANCNAEKIRASFEVQAREFAQAKAVVT 638
            ++YEL SALFYRADQERSNL+LHETS KS+VAEA CN+EK RASFE+QAREFAQAKAVV 
Sbjct: 2369 NKYELVSALFYRADQERSNLILHETSAKSIVAEATCNSEKTRASFEIQAREFAQAKAVVA 2428

Query: 639  EKAQEATTWMEQHGRILDALRGNLIPEINSCIKLSGSMDAFSLTSAVLVAGVPFSIVPEP 698
            E AQEATTWMEQHGRIL+ALR +LIPEI +CI LS   DA SLTSAVLVAGVP +IVPEP
Sbjct: 2429 EMAQEATTWMEQHGRILEALRSSLIPEIKACINLSSMQDALSLTSAVLVAGVPLTIVPEP 2488

Query: 699  TQVQCHDIDKDVSQLIAELDHGLSSVFIALQAYSLALQRILPLNYLTTTAVHGWAQVLQL 758
            TQ QCHDID++VSQLIAELDHGLS    ALQAYSLALQRILPLNYLTT+ +HGWAQVLQL
Sbjct: 2489 TQAQCHDIDREVSQLIAELDHGLSCSVTALQAYSLALQRILPLNYLTTSPLHGWAQVLQL 2548

Query: 759  SANAPSVDILSLARRQATELIVRIHGDNHDSIKQNHDDLRLKVEKYGVEIEKVEKECAEL 818
            S++  S DILS+  RQA EL+ +++GD+ DSIK +HDDL LKVEKY VEIEKVE+ECAEL
Sbjct: 2549 SSSTLSSDILSITIRQAAELVAKVNGDDFDSIKCDHDDLCLKVEKYAVEIEKVEEECAEL 2608

Query: 819  VNSIGSETESKAKDRFLLAFMKYMKSAGLVRKEDVSSSYQSGQLKNDGRKDAGLRGKQDE 878
            VNSIGSETESKAKDR L AFMKYM+SAGL RKED  SS Q GQ K+DG K+A  +G  +E
Sbjct: 2609 VNSIGSETESKAKDRLLSAFMKYMQSAGLARKEDTISSVQLGQFKHDGTKEARFQGALEE 2668

Query: 879  NKEKLLSVLNVAVTHLYDEVKCRVLDIFSDSAGGIKGNNRMQLDFGTLFCEFDEQVEKCI 938
             K+K+L +L++AV+ LYDEVK RVL IF++ A     +N +Q DFGT+FC+F+EQVEKCI
Sbjct: 2669 KKDKVLYILSIAVSSLYDEVKHRVLGIFTNLAERSSADNWLQSDFGTIFCKFEEQVEKCI 2728

Query: 939  LVAGFVNELWQSIGRDMYDNDADIECPNYHFERNWASIFKTSLLACKTLVGQMTEVVLPD 998
            LVAGF NEL Q I  DM     DIE   Y+ ERNWASIF+TSLL+CK LVG+MTE +LPD
Sbjct: 2729 LVAGFANELQQVINGDMPTVRTDIEHSRYYSERNWASIFRTSLLSCKGLVGKMTEDILPD 2788

Query: 999  VMRSTISFNSEVMDAFGLVSQIRGSIDTTLEQLVEVELERASLVELEQSYFVKVGLITEQ 1058
            V++S +SFNSEVMDAFG +SQIRGSID  LEQLVEVE+ERASLVELEQ+YF+KVG+ITEQ
Sbjct: 2789 VIKSIVSFNSEVMDAFGSLSQIRGSIDMALEQLVEVEIERASLVELEQNYFLKVGVITEQ 2848

Query: 1059 QLALEEAAVKGRDHLSWEEAEELASQEEACKAELNELHQTWNQRDMRSSSLMKQEADIRN 1118
            QLALEEAA+KGRDHLSWEEAEELASQEEAC+A+L++LHQTWNQ+D R+SSL+K+EA I+N
Sbjct: 2849 QLALEEAALKGRDHLSWEEAEELASQEEACRAQLDQLHQTWNQKDKRTSSLIKKEAVIKN 2908

Query: 1119 ALVSSERHFQSVISAEEFREPHILRSKALLAILVKPFMELESVDKTLASFCESVGSIPYG 1178
            ALVSS+R FQS+I   E REP     K LLA LVKPF ELES+DK L+SF  SV      
Sbjct: 2909 ALVSSKRLFQSLIIDGEEREPQGRGGKGLLAKLVKPFSELESIDKALSSFGGSVAFYSRA 2968

Query: 1179 TPKLADLINSGRSISECIWNFGSLSNGHSFFIWKMGIIDSFLDSCVHDVAASVDQNLGFD 1238
             P  ADL++S   +SE IW F SL N H+FF+W++G++DSFLDSC+HDV +SVDQ+LGFD
Sbjct: 2969 IPNPADLMSSAYPMSEYIWKFDSLLNSHTFFVWEIGVMDSFLDSCIHDVTSSVDQSLGFD 3028

Query: 1239 QLFNVVKKKLEVQLQEHVGLYLKERVAPIILAFLDKEIEHLKKLTESTKELTADDAKKDT 1298
            QLFNV+KKKLE+QLQEH+  YLKERVAPI+LA LDKE EHLK+LTE+TKEL  D  KKD 
Sbjct: 3029 QLFNVIKKKLEIQLQEHIVQYLKERVAPILLALLDKEKEHLKQLTEATKELAFDQGKKDL 3088

Query: 1299 GAVRRVQLMLAEYCNAHETARAARSAASLMKRQVNEFREALHKTSLEIVQMEWMHDATLT 1358
            GAV++VQLML EYCNAHETA AARSAASLMKRQVNE REA+ KTSLEIVQMEWMHD +LT
Sbjct: 3089 GAVKKVQLMLEEYCNAHETASAARSAASLMKRQVNELREAVLKTSLEIVQMEWMHDVSLT 3148

Query: 1359 PSYNSRITFQKYFSSDDDIYPIILNLSRPKLLETLQSSVTKIARSVESLQACERSSLTAE 1418
             S+N+R+ +QK+ ++DD +YPIILNL+RPKLLE++QS+V+KIARSVE LQACER+S+TAE
Sbjct: 3149 SSHNNRVIWQKFIANDDSLYPIILNLNRPKLLESMQSAVSKIARSVEFLQACERTSITAE 3208

Query: 1419 GQLERAMGWACGGPNSSAAGNSSTKTSGIPPEFHDHLMRRRQLLWEAREKASKIVNICMS 1478
            GQLERAMGWACGGPNSSA GN+STK+SGIPPEF+DHL RRRQLLWE REKAS ++ IC+S
Sbjct: 3209 GQLERAMGWACGGPNSSATGNTSTKSSGIPPEFNDHLTRRRQLLWEVREKASDMIKICVS 3268

Query: 1479 VLDFEASRDGVFRTPGEVYPARVGVDARSWQQVYLNAVTKLEVAYHSFTCAEQEWKLAQS 1538
            VL+FEASRDG+FR PG         D R+WQQ Y NA+T+L+V YHSFT  EQEWKLAQS
Sbjct: 3269 VLEFEASRDGIFRIPGG--------DGRTWQQAYFNALTRLDVTYHSFTRTEQEWKLAQS 3320

Query: 1539 SMEAASNGLYSATNELCIASLKAKSASGDLQSTVLTMRDCAYEASAALTAFGRVSRVHTA 1598
            S+EAASNGLY+ATNELCIAS+KAKSAS DLQSTVL MRDCAYEAS AL+AF RV+R HTA
Sbjct: 3321 SVEAASNGLYTATNELCIASVKAKSASADLQSTVLAMRDCAYEASVALSAFSRVTRGHTA 3380

Query: 1599 LTSESGSMLEEVLAITEDLHDVHSLGKEAAAINHSLMEDLSKANAVLLPLDSVLSKDVAA 1658
            LTSE GSMLEEVL ITE LHDVHSLGKEAAA++HSLMEDLSKAN VLLPL+SVLSKDVAA
Sbjct: 3381 LTSECGSMLEEVLVITEGLHDVHSLGKEAAAVHHSLMEDLSKANMVLLPLESVLSKDVAA 3440

Query: 1659 MSDAITSERETKMEVSPIHGQAIYQSYCLRVRDACQLLKPLLPSLMSSVKGLYSMLTRLA 1718
            M+DA+T ERETK+E+SPIHGQAIYQSYCLR+R+AC   KPL+PSL  SVKGLYSMLTRLA
Sbjct: 3441 MTDAMTRERETKLEISPIHGQAIYQSYCLRIREACPAFKPLVPSLTFSVKGLYSMLTRLA 3500

Query: 1719 RTASLHAGNLHKALEGLGESQEVKSQGVSLSRSDLTAADSSQFDEKGREAFSGSDSGSIK 1778
            RTASLHAGNLHKALEGLGESQEV+SQ ++LSR++L A+D+SQ   K RE FS SD G+  
Sbjct: 3501 RTASLHAGNLHKALEGLGESQEVRSQEINLSRTNL-ASDASQSGNKDREIFSRSDEGN-A 3558

Query: 1779 DDFLGVSGISLQDKGWISPPDSIYSSSSESAITSGEASLPDSSNNPVELTGQHPHGLNQ- 1837
            +D LGV+G+SLQDKGWISPPDS+YSSSSES I S EASLPDS   P E+  +  +G N  
Sbjct: 3559 EDLLGVAGLSLQDKGWISPPDSVYSSSSESVIISDEASLPDSHTAPAEMMARLSYGSNSR 3618

Query: 1838 ---------------------DSGQSVSKRTEVNNTDSGSVKFTVDEPIEYFKAQESPTG 1876
                                 + GQS SK TE NN+D+ SVK   +EP E+ KA  SP  
Sbjct: 3619 EGTDYLNSVSSSGTDFQEISLNCGQSESKYTEYNNSDASSVKSPTNEPSEHLKAAASPKN 3678

Query: 1877 EAVSVAVGSSQPLGNNSEVKFGVKDEVSSVNKVGIEEENNEDHVPNTHTVSRVARGKNAY 1936
            E+++V + +S+ L   +E  F  KDE SS N+V IE+EN E  +PNT   SR+ARGKNAY
Sbjct: 3679 ESITV-IDTSKSL---NEEDFEGKDETSSSNQVKIEDENREARLPNTDAGSRIARGKNAY 3734

Query: 1937 AISVLRRVEMKLDGRDIVENRNLSIAEQVDHLLKQATSVDNLCNMYEGWTPWI 1989
            AISVLRRVEMKLDGRDI +NR +SIAEQVD+LLKQATS+DNLCNMYEGWTPWI
Sbjct: 3735 AISVLRRVEMKLDGRDIADNREISIAEQVDYLLKQATSIDNLCNMYEGWTPWI 3787




Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255556185|ref|XP_002519127.1| conserved hypothetical protein [Ricinus communis] gi|223541790|gb|EEF43338.1| conserved hypothetical protein [Ricinus communis] Back     alignment and taxonomy information
>gi|297741391|emb|CBI32522.3| unnamed protein product [Vitis vinifera] Back     alignment and taxonomy information
>gi|356541123|ref|XP_003539032.1| PREDICTED: serine/threonine-protein kinase SMG1 [Glycine max] Back     alignment and taxonomy information
>gi|357473157|ref|XP_003606863.1| Serine/threonine protein kinase atr [Medicago truncatula] gi|355507918|gb|AES89060.1| Serine/threonine protein kinase atr [Medicago truncatula] Back     alignment and taxonomy information
>gi|449455326|ref|XP_004145404.1| PREDICTED: uncharacterized protein LOC101206782 [Cucumis sativus] gi|449471274|ref|XP_004153262.1| PREDICTED: uncharacterized protein LOC101222679 [Cucumis sativus] Back     alignment and taxonomy information
>gi|449511923|ref|XP_004164090.1| PREDICTED: uncharacterized LOC101222679 [Cucumis sativus] Back     alignment and taxonomy information
>gi|297832098|ref|XP_002883931.1| hypothetical protein ARALYDRAFT_899833 [Arabidopsis lyrata subsp. lyrata] gi|297329771|gb|EFH60190.1| hypothetical protein ARALYDRAFT_899833 [Arabidopsis lyrata subsp. lyrata] Back     alignment and taxonomy information
>gi|297601656|ref|NP_001051208.2| Os03g0738100 [Oryza sativa Japonica Group] gi|255674880|dbj|BAF13122.2| Os03g0738100 [Oryza sativa Japonica Group] Back     alignment and taxonomy information
>gi|31126780|gb|AAP44699.1| putative phosphatidylinositol 3-kinase-related protein kinase [Oryza sativa Japonica Group] gi|37999984|gb|AAR07071.1| putative phosphatidylinositol 3-kinase-related protein kinase [Oryza sativa Japonica Group] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query1989
ZFIN|ZDB-GENE-061013-7673640 smg1 "PI-3-kinase-related kina 0.357 0.195 0.328 2.9e-112
UNIPROTKB|F1PBU53632 SMG1 "Uncharacterized protein" 0.348 0.191 0.326 1.1e-108
UNIPROTKB|J9NTC03634 SMG1 "Uncharacterized protein" 0.347 0.190 0.331 2.4e-108
UNIPROTKB|F1MBL63637 SMG1 "Uncharacterized protein" 0.348 0.190 0.325 2.5e-108
UNIPROTKB|J3KRA93551 SMG1 "Serine/threonine-protein 0.347 0.194 0.329 2e-107
UNIPROTKB|Q96Q153661 SMG1 "Serine/threonine-protein 0.347 0.189 0.329 2.4e-107
UNIPROTKB|I3L0C13662 SMG1 "Serine/threonine-protein 0.347 0.188 0.329 2.4e-107
MGI|MGI:19197423658 Smg1 "SMG1 homolog, phosphatid 0.347 0.189 0.329 3.9e-106
UNIPROTKB|E1BW333665 SMG1 "Uncharacterized protein" 0.356 0.193 0.325 1e-104
FB|FBgn02639683218 nonC "no-on-and-no-off transie 0.249 0.154 0.319 2.1e-72
ZFIN|ZDB-GENE-061013-767 smg1 "PI-3-kinase-related kinase SMG-1" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
 Score = 1003 (358.1 bits), Expect = 2.9e-112, Sum P(4) = 2.9e-112
 Identities = 247/753 (32%), Positives = 392/753 (52%)

Query:    32 ILGCLRELYPRLIQDVELMINELGNLTVLWEELWLSTLQDLHADVMRRINVLKEEAARIA 91
             I+  L    P ++  V++++ EL  +T+LW+ELWL  LQ  H  V+RRI  L++E  R+ 
Sbjct:  1911 IVDKLSSANPTMVLQVQMLVGELRRVTLLWDELWLGVLQQQHMHVLRRIQQLEDEVKRVQ 1970

Query:    92 ENATLSQSEKKKINAAKYSAMMAPIVVALERRLASTSRKPETPHEIWFHEEFGEQLKSAI 151
              N TL + EK  I   K+SA+M P+V AL+   + T+   ETPHE WF E +G+ + +A+
Sbjct:  1971 NNNTLRKDEKVAIMREKHSALMKPVVFALDHVRSITAAPAETPHEEWFQETYGDAIHNAL 2030

Query:   152 LNFKTP--PASAAALGDVWRPFDNIAASLASH-QRKSS--VSLSEVAPQLSLLSSSDVPM 206
                ++P  PA+ A+    W PF  I  SL    Q+++S  + L E++P+L+ ++++++ +
Sbjct:  2031 ERLRSPLNPANPASS---WVPFKQIMLSLQQRAQKRASYLLRLDEISPRLTAMANTEMAL 2087

Query:   207 PG--FEKQVATSESDGGLTATL------RGIVTIASFSEEVSILSTKTKPKKLVILGQML 258
             PG        T +S G     L      + +  + S       L    +   L       
Sbjct:  2088 PGEVSATDAVTIQSVGNTITILPTKTKPKKLYFLGSDGRNYPYLFKGLEDLHLDERIMQF 2147

Query:   259 LQAVNSFLRSSPATRSHSLGIRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQ 318
             L  VN+         S     R+YSVTP+  R+GLIQWVD    ++ ++K WQ R  + Q
Sbjct:  2148 LSIVNTMFTKVNQQESPRFQARHYSVTPLGTRSGLIQWVDGATPLFGLYKRWQQREAVVQ 2207

Query:   319 FSAIGAGNAKXXXXXXXXXXXDMFYGKIIPALKEKGIRRVISRRDWPHDVKRKVLLDLMK 378
                      +           +++Y KI PALK  G+   +SRRDWP  V R VL +LM+
Sbjct:  2208 AQKAQDSFQQPQNLPMVPRPSELYYSKISPALKAVGLSLDVSRRDWPLSVMRDVLRELME 2267

Query:   379 EVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGD 438
               P  LL +E+WC+      +    + Y+ S A MSMVG+I+GLGDRHLDN+L+D ++G+
Sbjct:  2268 ATPPNLLAKELWCSCTTPSEWWSVTQTYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGE 2327

Query:   439 IVHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDI 498
             +VHIDYNVCF+KG+ L+VPE VPFR+T  IE ALG+TG+EG FR +CE VV ++R+ ++ 
Sbjct:  2328 VVHIDYNVCFEKGKSLRVPEKVPFRMTHNIETALGVTGVEGIFRLSCEQVVQIMRRGRET 2387

Query:   499 LLMLLEVFVWDPLIEWTRG-DFHDDAAI---GGEE------RKGMELAVSLSLFASRVQE 548
             LL LLE FV+DPL++WT G +     A+   GG++      ++ ME  ++ SLF+SRV E
Sbjct:  2388 LLTLLEAFVYDPLVDWTAGGEVGFAGAVYGGGGQQAENKQSKREMERDITRSLFSSRVAE 2447

Query:   549 IRVPLQEHHDLLLATLPAVELALERFADVLSQYELASALFYRADQERSNLVLHETSTKSM 608
             I+V   ++ D +   LP +E A++ + ++  Q      +  +  +E   L   +T     
Sbjct:  2448 IKVNWFKNRDEMTGVLPQLEEAVDEYLNLQEQLTQVEKVQGKLLEELEFLEGADTRADHP 2507

Query:   609 VAEANCNAEKIRASFEVQAREFAQAKAVVTEKAQEATTWMEQHGRILDALRG----NLIP 664
             +        +     ++Q+R+     A+   K  +   W+ Q+     +L      +L+ 
Sbjct:  2508 IHSLE---HRYSEHTQLQSRQRTVQDAI-QGKLSDLDQWISQYQAAFASLEATQLASLLQ 2563

Query:   665 EINSCIKLSGSMDAFSLTSAVLVAGVPFSIVPEPTQVQCHDIDKDVSQLIAELDHGLSSV 724
             EI+S I L G       TS +  AG    I       QC  ++ +VS L+ +    L   
Sbjct:  2564 EISSPIDL-GPPSYVPATSFLQNAGQAHLIS------QCEALEAEVSALLQQRRSQLRGC 2616

Query:   725 FIALQAYSLALQRILPLNYLTTTAVHGWAQVLQ 757
                L +Y+  +  + P   L     H W Q ++
Sbjct:  2617 LEHLHSYA-TVALLYPRAVLHRHRAHTWKQWME 2648


GO:0016773 "phosphotransferase activity, alcohol group as acceptor" evidence=IEA
GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA
GO:0016310 "phosphorylation" evidence=IEA
GO:0005524 "ATP binding" evidence=IEA
GO:0016740 "transferase activity" evidence=IEA
GO:0016301 "kinase activity" evidence=IEA
GO:0000166 "nucleotide binding" evidence=IEA
UNIPROTKB|F1PBU5 SMG1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|J9NTC0 SMG1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|F1MBL6 SMG1 "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|J3KRA9 SMG1 "Serine/threonine-protein kinase SMG1" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|Q96Q15 SMG1 "Serine/threonine-protein kinase SMG1" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|I3L0C1 SMG1 "Serine/threonine-protein kinase SMG1" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
MGI|MGI:1919742 Smg1 "SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans)" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
UNIPROTKB|E1BW33 SMG1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
FB|FBgn0263968 nonC "no-on-and-no-off transient C" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Fail to connect to STRING server


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1989
cd05170307 cd05170, PIKKc_SMG1, Suppressor of morphogenetic e 1e-137
cd05169280 cd05169, PIKKc_TOR, TOR (Target of rapamycin), cat 5e-66
cd05171279 cd05171, PIKKc_ATM, Ataxia telangiectasia mutated 2e-62
cd00892237 cd00892, PIKKc_ATR, ATR (Ataxia telangiectasia and 5e-52
COG50322105 COG5032, TEL1, Phosphatidylinositol kinase and pro 8e-44
cd05164222 cd05164, PIKKc, Phosphoinositide 3-kinase-related 2e-42
smart00146240 smart00146, PI3Kc, Phosphoinositide 3-kinase, cata 3e-42
pfam00454233 pfam00454, PI3_PI4_kinase, Phosphatidylinositol 3- 2e-40
cd00142219 cd00142, PI3Kc_like, Phosphoinositide 3-kinase (PI 9e-34
cd05172235 cd05172, PIKKc_DNA-PK, DNA-dependent protein kinas 4e-27
cd05164222 cd05164, PIKKc, Phosphoinositide 3-kinase-related 1e-14
cd00892237 cd00892, PIKKc_ATR, ATR (Ataxia telangiectasia and 5e-12
cd05172235 cd05172, PIKKc_DNA-PK, DNA-dependent protein kinas 1e-11
pfam0226033 pfam02260, FATC, FATC domain 6e-11
cd05163253 cd05163, TRRAP, TRansformation/tRanscription domai 4e-09
cd05168293 cd05168, PI4Kc_III_beta, Phosphoinositide 4-kinase 7e-09
cd05167311 cd05167, PI4Kc_III_alpha, Phosphoinositide 4-kinas 5e-07
cd00896350 cd00896, PI3Kc_III, Phosphoinositide 3-kinase (PI3 9e-07
cd05173362 cd05173, PI3Kc_IA_beta, Phosphoinositide 3-kinase 3e-06
COG50322105 COG5032, TEL1, Phosphatidylinositol kinase and pro 1e-05
cd00893289 cd00893, PI4Kc_III, Phosphoinositide 4-kinase (PI4 6e-05
cd00891352 cd00891, PI3Kc, Phosphoinositide 3-kinase (PI3K), 7e-05
cd05166353 cd05166, PI3Kc_II, Phosphoinositide 3-kinase (PI3K 7e-05
cd05165366 cd05165, PI3Kc_I, Phosphoinositide 3-kinase (PI3K) 1e-04
cd00142219 cd00142, PI3Kc_like, Phosphoinositide 3-kinase (PI 2e-04
cd05174361 cd05174, PI3Kc_IA_delta, Phosphoinositide 3-kinase 6e-04
cd00894365 cd00894, PI3Kc_IB_gamma, Phosphoinositide 3-kinase 0.003
>gnl|CDD|119430 cd05170, PIKKc_SMG1, Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
 Score =  428 bits (1102), Expect = e-137
 Identities = 144/307 (46%), Positives = 193/307 (62%), Gaps = 22/307 (7%)

Query: 232 IASFSEEVSILSTKTKPKKLVILGQ----------------------MLLQAVNSFLRSS 269
           I S    V+IL TKTKPKKL  LG                         L  VN+   S 
Sbjct: 1   IESVGSTVTILPTKTKPKKLAFLGSDGKKYTYLFKGREDLHLDERIMQFLSIVNTMFASI 60

Query: 270 PATRSHSLGIRYYSVTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQFSAIGAGNAKS 329
               S     R+YSVTP+  R+GLIQWVD    ++ ++K WQ R  + Q      G    
Sbjct: 61  KDQESPRFRARHYSVTPLGPRSGLIQWVDGATPLFGLYKRWQQREAVLQAQKSQVGYQNP 120

Query: 330 SVPPPVPRPSDMFYGKIIPALKEKGIRRVISRRDWPHDVKRKVLLDLMKEVPRQLLHQEI 389
            +P  VPRPSD+FY KI PALK  G+   +SRRDWP  V R+VL +LM+E P+ LL +E+
Sbjct: 121 QIPGIVPRPSDLFYNKITPALKAHGLSLDVSRRDWPLSVLRQVLDELMQETPKDLLAREL 180

Query: 390 WCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFD 449
           WC+S     +    +RY+ S A MSM+G+++GLGDRHLDN+L+D  +G++VHIDYNVCF+
Sbjct: 181 WCSSTTSSEWWSVTQRYARSTAVMSMIGYVIGLGDRHLDNVLIDLKTGEVVHIDYNVCFE 240

Query: 450 KGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWD 509
           KG+ L++PE VPFR+TQ IE ALGLTG+EG FR +CE V+ ++R+ ++ LL LLE FV+D
Sbjct: 241 KGKSLRIPEKVPFRMTQNIETALGLTGVEGVFRLSCEQVLHIMRRGRETLLTLLEAFVYD 300

Query: 510 PLIEWTR 516
           PL++WT 
Sbjct: 301 PLVDWTA 307


SMG-1 is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). In addition to its catalytic domain, SMG-1 contains a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. SMG-1 plays a critical role in the mRNA surveillance mechanism known as non-sense mediated mRNA decay (NMD). NMD protects the cells from the accumulation of aberrant mRNAs with premature termination codons (PTCs) generated by genome mutations and by errors during transcription and splicing. SMG-1 phosphorylates Upf1, another central component of NMD, at the C-terminus upon recognition of PTCs. The phosphorylation/dephosphorylation cycle of Upf1 is essential for promoting NMD. Length = 307

>gnl|CDD|119429 cd05169, PIKKc_TOR, TOR (Target of rapamycin), catalytic domain; The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119431 cd05171, PIKKc_ATM, Ataxia telangiectasia mutated (ATM), catalytic domain; The ATM catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119418 cd00892, PIKKc_ATR, ATR (Ataxia telangiectasia and Rad3-related), catalytic domain; The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|227365 COG5032, TEL1, Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family [Signal transduction mechanisms / Cell division and chromosome partitioning / Chromatin structure and dynamics / DNA replication, recombination, and repair / Intracellular trafficking and secretion] Back     alignment and domain information
>gnl|CDD|119424 cd05164, PIKKc, Phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily, catalytic domain; The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|214538 smart00146, PI3Kc, Phosphoinositide 3-kinase, catalytic domain Back     alignment and domain information
>gnl|CDD|189554 pfam00454, PI3_PI4_kinase, Phosphatidylinositol 3- and 4-kinase Back     alignment and domain information
>gnl|CDD|119416 cd00142, PI3Kc_like, Phosphoinositide 3-kinase (PI3K)-like family, catalytic domain; The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119432 cd05172, PIKKc_DNA-PK, DNA-dependent protein kinase (DNA-PK), catalytic domain; The DNA-PK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119424 cd05164, PIKKc, Phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily, catalytic domain; The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119418 cd00892, PIKKc_ATR, ATR (Ataxia telangiectasia and Rad3-related), catalytic domain; The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119432 cd05172, PIKKc_DNA-PK, DNA-dependent protein kinase (DNA-PK), catalytic domain; The DNA-PK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|202180 pfam02260, FATC, FATC domain Back     alignment and domain information
>gnl|CDD|119423 cd05163, TRRAP, TRansformation/tRanscription domain-Associated Protein (TRRAP), pseudokinase domain; The TRRAP catalytic domain is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119428 cd05168, PI4Kc_III_beta, Phosphoinositide 4-kinase (PI4K), Type III, beta isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119427 cd05167, PI4Kc_III_alpha, Phosphoinositide 4-kinase (PI4K), Type III, alpha isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119422 cd00896, PI3Kc_III, Phosphoinositide 3-kinase (PI3K), class III, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119433 cd05173, PI3Kc_IA_beta, Phosphoinositide 3-kinase (PI3K), class IA, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|227365 COG5032, TEL1, Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family [Signal transduction mechanisms / Cell division and chromosome partitioning / Chromatin structure and dynamics / DNA replication, recombination, and repair / Intracellular trafficking and secretion] Back     alignment and domain information
>gnl|CDD|119419 cd00893, PI4Kc_III, Phosphoinositide 4-kinase (PI4K), Type III, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119417 cd00891, PI3Kc, Phosphoinositide 3-kinase (PI3K), catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119426 cd05166, PI3Kc_II, Phosphoinositide 3-kinase (PI3K), class II, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119425 cd05165, PI3Kc_I, Phosphoinositide 3-kinase (PI3K), class I, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119416 cd00142, PI3Kc_like, Phosphoinositide 3-kinase (PI3K)-like family, catalytic domain; The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119434 cd05174, PI3Kc_IA_delta, Phosphoinositide 3-kinase (PI3K), class IA, delta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119420 cd00894, PI3Kc_IB_gamma, Phosphoinositide 3-kinase (PI3K), class IB, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 1989
cd05170307 PIKKc_SMG1 Suppressor of morphogenetic effect on g 100.0
KOG08912341 consensus DNA-dependent protein kinase [Replicatio 100.0
KOG08902382 consensus Protein kinase of the PI-3 kinase family 100.0
KOG08922806 consensus Protein kinase ATM/Tel1, involved in tel 100.0
COG50322105 TEL1 Phosphatidylinositol kinase and protein kinas 100.0
cd05169280 PIKKc_TOR TOR (Target of rapamycin), catalytic dom 100.0
cd05171279 PIKKc_ATM Ataxia telangiectasia mutated (ATM), cat 100.0
cd05163253 TRRAP TRansformation/tRanscription domain-Associat 100.0
cd05172235 PIKKc_DNA-PK DNA-dependent protein kinase (DNA-PK) 100.0
cd00892237 PIKKc_ATR ATR (Ataxia telangiectasia and Rad3-rela 100.0
cd05164222 PIKKc Phosphoinositide 3-kinase-related protein ki 100.0
cd00142219 PI3Kc_like Phosphoinositide 3-kinase (PI3K)-like f 100.0
smart00146202 PI3Kc Phosphoinositide 3-kinase, catalytic domain. 100.0
PF00454235 PI3_PI4_kinase: Phosphatidylinositol 3- and 4-kina 100.0
cd00891352 PI3Kc Phosphoinositide 3-kinase (PI3K), catalytic 100.0
cd05166353 PI3Kc_II Phosphoinositide 3-kinase (PI3K), class I 100.0
cd00896350 PI3Kc_III Phosphoinositide 3-kinase (PI3K), class 100.0
cd05165366 PI3Kc_I Phosphoinositide 3-kinase (PI3K), class I, 100.0
KOG08893550 consensus Histone acetyltransferase SAGA, TRRAP/TR 100.0
cd05168293 PI4Kc_III_beta Phosphoinositide 4-kinase (PI4K), T 100.0
cd05177354 PI3Kc_C2_gamma Phosphoinositide 3-kinase (PI3K), c 100.0
cd05173362 PI3Kc_IA_beta Phosphoinositide 3-kinase (PI3K), cl 100.0
cd05174361 PI3Kc_IA_delta Phosphoinositide 3-kinase (PI3K), c 100.0
cd00894365 PI3Kc_IB_gamma Phosphoinositide 3-kinase (PI3K), c 100.0
cd00893289 PI4Kc_III Phosphoinositide 4-kinase (PI4K), Type I 100.0
cd05176353 PI3Kc_C2_alpha Phosphoinositide 3-kinase (PI3K), c 100.0
cd05167311 PI4Kc_III_alpha Phosphoinositide 4-kinase (PI4K), 100.0
cd05175366 PI3Kc_IA_alpha Phosphoinositide 3-kinase (PI3K), c 100.0
cd00895354 PI3Kc_C2_beta Phosphoinositide 3-kinase (PI3K), cl 100.0
KOG09041076 consensus Phosphatidylinositol 3-kinase catalytic 99.92
KOG0906843 consensus Phosphatidylinositol 3-kinase VPS34, inv 99.91
KOG09051639 consensus Phosphoinositide 3-kinase [Signal transd 99.88
KOG0903847 consensus Phosphatidylinositol 4-kinase, involved 99.84
KOG09021803 consensus Phosphatidylinositol 4-kinase [Signal tr 99.81
PTZ003031374 phosphatidylinositol kinase; Provisional 99.69
PF08771100 Rapamycin_bind: Rapamycin binding domain; InterPro 99.44
PF0226033 FATC: FATC domain; InterPro: IPR003152 The FATC do 99.34
KOG08912341 consensus DNA-dependent protein kinase [Replicatio 98.89
KOG08902382 consensus Protein kinase of the PI-3 kinase family 98.69
KOG08922806 consensus Protein kinase ATM/Tel1, involved in tel 98.28
COG50322105 TEL1 Phosphatidylinositol kinase and protein kinas 98.01
PF0226033 FATC: FATC domain; InterPro: IPR003152 The FATC do 88.01
>cd05170 PIKKc_SMG1 Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
Probab=100.00  E-value=5e-65  Score=591.85  Aligned_cols=285  Identities=51%  Similarity=0.933  Sum_probs=258.2

Q ss_pred             EEEEeceeEEecCCCCceEEEEEcH----------------------HHHHHHHHHHhcCCccCCCccceecceeeEecC
Q 037207          232 IASFSEEVSILSTKTKPKKLVILGQ----------------------MLLQAVNSFLRSSPATRSHSLGIRYYSVTPISG  289 (1989)
Q Consensus       232 I~rF~p~V~VL~SKqrPRRLtI~GS----------------------QLFrLINsLL~kdkETRRR~L~IrtYsVIPLSp  289 (1989)
                      |++|.|+|.|++||++||||+|+|+                      |||++||.+|.++++|++|+|.|++|.||||++
T Consensus         1 I~~f~~~v~V~~Sk~~Pkri~~~gsDG~~y~fLlK~~dDLR~D~RimQlf~l~N~ll~~~~~~~~r~L~i~tY~ViPLs~   80 (307)
T cd05170           1 IESVGSTVTILPTKTKPKKLAFLGSDGKKYTYLFKGREDLHLDERIMQFLSIVNTMFASIKDQESPRFRARHYSVTPLGP   80 (307)
T ss_pred             CccccCeEEEEecCCCceEEEEECCCCCEEEEEecCCCcccHHHHHHHHHHHHHHHHHhChhhhccCceeecceEEEcCC
Confidence            6799999999999999999999997                      999999999999999999999999999999999


Q ss_pred             CcceeeecCCcccHHHHHHHHHHHHHHHHHhhhccCCCCCCCCCCCCCCchhhhhhhhHHHHhhcccccccCCCCChHHH
Q 037207          290 RAGLIQWVDNVISIYSVFKSWQHRAQLAQFSAIGAGNAKSSVPPPVPRPSDMFYGKIIPALKEKGIRRVISRRDWPHDVK  369 (1989)
Q Consensus       290 ~sGLIEWVpntvTL~eIyk~~~~R~~i~q~~~~~~~n~k~~~~~~vprP~dlfy~kl~~aLke~gi~~v~sR~dwp~evk  369 (1989)
                      ++||||||+|++||++||+.|+++.++....................+|.++||+++.+.+++.++....++.+|+.+++
T Consensus        81 ~~GLIEwv~~~~tl~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~  160 (307)
T cd05170          81 RSGLIQWVDGATPLFGLYKRWQQREAVLQAQKSQVGYQNPQIPGIVPRPSDLFYNKITPALKAHGLSLDVSRRDWPLSVL  160 (307)
T ss_pred             CcceEEEcCCChhHHHHHHHHHHhhhhhhhhhhccccccccccccccchhHHHHHHHHHHHHhhccccccchhhccHHHH
Confidence            99999999999999999999998876643211000000000111234678899999988888777655556788999999


Q ss_pred             HHHHHHHHhccchhhHHHHHHhhcCChhHHHHHHHHHHHhhhhHHHHHhhcccCCCCCCceEEecCCCcEEEEecccccc
Q 037207          370 RKVLLDLMKEVPRQLLHQEIWCASEGFKAFSLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFD  449 (1989)
Q Consensus       370 reVF~eL~ketP~dlL~r~Lw~~S~sse~w~~~RknFTrSLAVmSmVGYILGLGDRHPsNILIDr~TGeVVHIDFG~cFe  449 (1989)
                      +++|.++++++|+++|++++|..++++++||.+|++|++|+|+|||+|||||||||||+||||++.||+|+|||||+||+
T Consensus       161 ~~~~~~i~~~~~~~~l~~~~~~~~~~~~~w~~~r~~f~~s~A~~s~~~yilglgDRh~~NIli~~~tG~v~hiDf~~~f~  240 (307)
T cd05170         161 RQVLDELMQETPKDLLARELWCSSTTSSEWWSVTQRYARSTAVMSMIGYVIGLGDRHLDNVLIDLKTGEVVHIDYNVCFE  240 (307)
T ss_pred             HHHHHHHHHhCCHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHccCCCCCCccEEEEcCCCcEEEEeeHhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCcCCCcCCccccHHHHHHhccCCccchHHHHHHHHHHHHhhChhHHHHHHHHHhhCCCccccc
Q 037207          450 KGQRLKVPEIVPFRLTQTIEAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIEWTR  516 (1989)
Q Consensus       450 kGkrL~vPE~VPFRLTrNIv~ALGptGVEG~FRssceatmr~LRknkd~LlsLLEaFVrDPLvdW~~  516 (1989)
                      +|+.+++||.|||||||||+++||+.|++|.|+.+|+.++++||++++.|+++|++|+||||++|+.
T Consensus       241 ~~~~l~~pE~VPFRLT~~~~~~lg~~g~~G~f~~~~~~~~~~Lr~~~~~l~~~l~~fv~DPl~~W~~  307 (307)
T cd05170         241 KGKSLRIPEKVPFRMTQNIETALGLTGVEGVFRLSCEQVLHIMRRGRETLLTLLEAFVYDPLVDWTA  307 (307)
T ss_pred             ccCCCCCCCCCCeeeCHHHHHHhCCCCCchhHHHHHHHHHHHHHcCHHHHHHHHHHHhhCccccccC
Confidence            9998999999999999999999999999999999999999999999999999999999999999973



SMG-1 is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). In addition to its catalytic domain, SMG-1 contains a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. SMG-1 plays a critical role in the mRNA surveillance mechanism known as non-sense mediated mRNA decay (NMD). NMD protects the cells from the accumulation of aberrant mRNAs with premature termination codons (PTCs) generated by geno

>KOG0891 consensus DNA-dependent protein kinase [Replication, recombination and repair] Back     alignment and domain information
>KOG0890 consensus Protein kinase of the PI-3 kinase family involved in mitotic growth, DNA repair and meiotic recombination [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
>KOG0892 consensus Protein kinase ATM/Tel1, involved in telomere length regulation and DNA repair [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
>COG5032 TEL1 Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family [Signal transduction mechanisms / Cell division and chromosome partitioning / Chromatin structure and dynamics / DNA replication, recombination, and repair / Intracellular trafficking and secretion] Back     alignment and domain information
>cd05169 PIKKc_TOR TOR (Target of rapamycin), catalytic domain; The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05171 PIKKc_ATM Ataxia telangiectasia mutated (ATM), catalytic domain; The ATM catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05163 TRRAP TRansformation/tRanscription domain-Associated Protein (TRRAP), pseudokinase domain; The TRRAP catalytic domain is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05172 PIKKc_DNA-PK DNA-dependent protein kinase (DNA-PK), catalytic domain; The DNA-PK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00892 PIKKc_ATR ATR (Ataxia telangiectasia and Rad3-related), catalytic domain; The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05164 PIKKc Phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily, catalytic domain; The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00142 PI3Kc_like Phosphoinositide 3-kinase (PI3K)-like family, catalytic domain; The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>smart00146 PI3Kc Phosphoinositide 3-kinase, catalytic domain Back     alignment and domain information
>PF00454 PI3_PI4_kinase: Phosphatidylinositol 3- and 4-kinase; InterPro: IPR000403 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases Back     alignment and domain information
>cd00891 PI3Kc Phosphoinositide 3-kinase (PI3K), catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05166 PI3Kc_II Phosphoinositide 3-kinase (PI3K), class II, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00896 PI3Kc_III Phosphoinositide 3-kinase (PI3K), class III, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05165 PI3Kc_I Phosphoinositide 3-kinase (PI3K), class I, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>KOG0889 consensus Histone acetyltransferase SAGA, TRRAP/TRA1 component, PI-3 kinase superfamily [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
>cd05168 PI4Kc_III_beta Phosphoinositide 4-kinase (PI4K), Type III, beta isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05177 PI3Kc_C2_gamma Phosphoinositide 3-kinase (PI3K), class II, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05173 PI3Kc_IA_beta Phosphoinositide 3-kinase (PI3K), class IA, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05174 PI3Kc_IA_delta Phosphoinositide 3-kinase (PI3K), class IA, delta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00894 PI3Kc_IB_gamma Phosphoinositide 3-kinase (PI3K), class IB, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00893 PI4Kc_III Phosphoinositide 4-kinase (PI4K), Type III, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05176 PI3Kc_C2_alpha Phosphoinositide 3-kinase (PI3K), class II, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05167 PI4Kc_III_alpha Phosphoinositide 4-kinase (PI4K), Type III, alpha isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05175 PI3Kc_IA_alpha Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00895 PI3Kc_C2_beta Phosphoinositide 3-kinase (PI3K), class II, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>KOG0904 consensus Phosphatidylinositol 3-kinase catalytic subunit (p110) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0906 consensus Phosphatidylinositol 3-kinase VPS34, involved in signal transduction [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] Back     alignment and domain information
>KOG0905 consensus Phosphoinositide 3-kinase [Signal transduction mechanisms] Back     alignment and domain information
>KOG0903 consensus Phosphatidylinositol 4-kinase, involved in intracellular trafficking and secretion [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] Back     alignment and domain information
>KOG0902 consensus Phosphatidylinositol 4-kinase [Signal transduction mechanisms] Back     alignment and domain information
>PTZ00303 phosphatidylinositol kinase; Provisional Back     alignment and domain information
>PF08771 Rapamycin_bind: Rapamycin binding domain; InterPro: IPR009076 Rapamycin and FK506 are potent immunosuppressive agents that bind to the FK506-binding protein (FKBP12), inhibiting its peptidyl-prolyl isomerase activity Back     alignment and domain information
>PF02260 FATC: FATC domain; InterPro: IPR003152 The FATC domain is found at the C-terminal end of the PIK-related kinases Back     alignment and domain information
>KOG0891 consensus DNA-dependent protein kinase [Replication, recombination and repair] Back     alignment and domain information
>KOG0890 consensus Protein kinase of the PI-3 kinase family involved in mitotic growth, DNA repair and meiotic recombination [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
>KOG0892 consensus Protein kinase ATM/Tel1, involved in telomere length regulation and DNA repair [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
>COG5032 TEL1 Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family [Signal transduction mechanisms / Cell division and chromosome partitioning / Chromatin structure and dynamics / DNA replication, recombination, and repair / Intracellular trafficking and secretion] Back     alignment and domain information
>PF02260 FATC: FATC domain; InterPro: IPR003152 The FATC domain is found at the C-terminal end of the PIK-related kinases Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1989
2y3a_A1092 Crystal Structure Of P110beta In Complex With Icsh2 6e-07
2x6f_A696 The Crystal Structure Of The Drosophila Class Iii P 2e-05
4anv_A980 Complexes Of Pi3kgamma With Isoform Selective Inhib 2e-05
3l54_A966 Structure Of Pi3k Gamma With Inhibitor Length = 966 2e-05
4dk5_A959 Crystal Structure Of Human Pi3k-Gamma In Complex Wi 2e-05
3ene_A959 Complex Of Pi3k Gamma With An Inhibitor Length = 95 2e-05
1e8x_A961 Structural Insights Into Phoshoinositide 3-Kinase E 2e-05
1e7u_A961 Structure Determinants Of Phosphoinositide 3-Kinase 2e-05
1e8y_A966 Structure Determinants Of Phosphoinositide 3-Kinase 2e-05
3dbs_A960 Structure Of Pi3k Gamma In Complex With Gdc0941 Len 2e-05
3cst_A966 Crystal Structure Of Pi3k P110gamma Catalytical Dom 2e-05
3qaq_A960 Crystal Structure Of Pi3k-Gamma In Complex With Tri 2e-05
3apc_A966 Crystal Structure Of Human Pi3k-Gamma In Complex Wi 2e-05
1he8_A965 Ras G12v-Pi 3-Kinase Gamma Complex Length = 965 2e-05
4anu_A980 Complexes Of Pi3kgamma With Isoform Selective Inhib 2e-05
3nzs_A954 Structure-Based Optimization Of Pyrazolo -Pyrimidin 2e-05
4ajw_A934 Discovery And Optimization Of New Benzimidazole- An 3e-05
4anx_A980 Complexes Of Pi3kgamma With Isoform Selective Inhib 4e-05
2wxf_A940 The Crystal Structure Of The Murine Class Ia Pi 3-K 4e-05
3ls8_A614 Crystal Structure Of Human Pik3c3 In Complex With 3 7e-05
3ihy_A600 Human Pik3c3 Crystal Structure Length = 600 7e-05
>pdb|2Y3A|A Chain A, Crystal Structure Of P110beta In Complex With Icsh2 Of P85beta And The Drug Gdc-0941 Length = 1092 Back     alignment and structure

Iteration: 1

Score = 54.7 bits (130), Expect = 6e-07, Method: Compositional matrix adjust. Identities = 37/143 (25%), Positives = 67/143 (46%), Gaps = 12/143 (8%) Query: 403 LKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDIVHIDYNVCFDKG------QRLKV 456 ++ ++ S A + ++LG+GDRH DNI++ +G + HID+ +R +V Sbjct: 920 IEEFTLSCAGYCVASYVLGIGDRHSDNIMVK-KTGQLFHIDFGHILGNFKSKFGIKRERV 978 Query: 457 PEIVPFRLTQTI-EAALGLTGIEGTFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIEWT 515 P I+ + I + G T G FR CE +LR++ ++ + L + + L E T Sbjct: 979 PFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELT 1038 Query: 516 RGD----FHDDAAIGGEERKGME 534 D A+G E + ++ Sbjct: 1039 SVKDIQYLKDSLALGKSEEEALK 1061
>pdb|2X6F|A Chain A, The Crystal Structure Of The Drosophila Class Iii Pi3-Kinase Vps34 In Complex With 3-Methyladenine Length = 696 Back     alignment and structure
>pdb|4ANV|A Chain A, Complexes Of Pi3kgamma With Isoform Selective Inhibitors Length = 980 Back     alignment and structure
>pdb|3L54|A Chain A, Structure Of Pi3k Gamma With Inhibitor Length = 966 Back     alignment and structure
>pdb|4DK5|A Chain A, Crystal Structure Of Human Pi3k-Gamma In Complex With A Pyridyl- Triazine Inhibitor Length = 959 Back     alignment and structure
>pdb|3ENE|A Chain A, Complex Of Pi3k Gamma With An Inhibitor Length = 959 Back     alignment and structure
>pdb|1E8X|A Chain A, Structural Insights Into Phoshoinositide 3-Kinase Enzymatic Mechanism And Signalling Length = 961 Back     alignment and structure
>pdb|1E8Y|A Chain A, Structure Determinants Of Phosphoinositide 3-Kinase Inhibition By Wortmannin, Ly294002, Quercetin, Myricetin And Staurosporine Length = 966 Back     alignment and structure
>pdb|3DBS|A Chain A, Structure Of Pi3k Gamma In Complex With Gdc0941 Length = 960 Back     alignment and structure
>pdb|3CST|A Chain A, Crystal Structure Of Pi3k P110gamma Catalytical Domain In Complex With Organoruthenium Inhibitor E5e2 Length = 966 Back     alignment and structure
>pdb|3QAQ|A Chain A, Crystal Structure Of Pi3k-Gamma In Complex With Triazine-Benzimidazole 1 Length = 960 Back     alignment and structure
>pdb|3APC|A Chain A, Crystal Structure Of Human Pi3k-Gamma In Complex With Ch5132799 Length = 966 Back     alignment and structure
>pdb|1HE8|A Chain A, Ras G12v-Pi 3-Kinase Gamma Complex Length = 965 Back     alignment and structure
>pdb|4ANU|A Chain A, Complexes Of Pi3kgamma With Isoform Selective Inhibitors. Length = 980 Back     alignment and structure
>pdb|3NZS|A Chain A, Structure-Based Optimization Of Pyrazolo -Pyrimidine And -Pyridine Inhibitors Of Pi3-Kinase Length = 954 Back     alignment and structure
>pdb|4AJW|A Chain A, Discovery And Optimization Of New Benzimidazole- And Benzoxazole- Pyrimidone Selective Pi3kbeta Inhibitors For The Treatment Of Phosphatase And Tensin Homologue (Pten)-Deficient Cancers Length = 934 Back     alignment and structure
>pdb|4ANX|A Chain A, Complexes Of Pi3kgamma With Isoform Selective Inhibitors Length = 980 Back     alignment and structure
>pdb|2WXF|A Chain A, The Crystal Structure Of The Murine Class Ia Pi 3-Kinase P110delta In Complex With Pik-39. Length = 940 Back     alignment and structure
>pdb|3LS8|A Chain A, Crystal Structure Of Human Pik3c3 In Complex With 3-[4-(4- Morpholinyl)thieno[3,2-D]pyrimidin-2-Yl]-Phenol Length = 614 Back     alignment and structure
>pdb|3IHY|A Chain A, Human Pik3c3 Crystal Structure Length = 600 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1989
1e7u_A961 Phosphatidylinositol 3-kinase catalytic subunit; p 2e-16
3ls8_A614 Phosphatidylinositol 3-kinase catalytic subunit ty 2e-15
2x6h_A696 GH13170P, VPS34, phosphotidylinositol 3 kinase 59F 3e-15
3hhm_A1091 Phosphatidylinositol-4,5-bisphosphate 3-kinase cat 2e-13
2wxf_A940 Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca 3e-13
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-12
1vt4_I1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-11
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-11
1vt4_I1221 APAF-1 related killer DARK; drosophila apoptosome, 7e-11
1vt4_I1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-08
2y3a_A1092 Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca 2e-12
1w1n_A33 Phosphatidylinositol 3-kinase TOR1; target of rapa 5e-12
2npu_A126 FKBP12-rapamycin complex-associated protein; four- 7e-08
>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A Length = 614 Back     alignment and structure
>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* Length = 696 Back     alignment and structure
>3hhm_A Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_A 2rd0_A 4a55_A* 2enq_A Length = 1091 Back     alignment and structure
>2wxf_A Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca subunit delta isoform; transferase, phosphoprotein, isoform-specific inhibitors; HET: 039; 1.90A {Mus musculus} PDB: 2wxg_A* 2wxh_A* 2wxi_A* 2wxj_A* 2wxk_A* 2wxl_A* 2wxm_A* 2wxn_A* 2wxo_A* 2wxp_A* 2wxq_A* 2wxr_A 2x38_A* Length = 940 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>2y3a_A Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca subunit beta isoform; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} Length = 1092 Back     alignment and structure
>1w1n_A Phosphatidylinositol 3-kinase TOR1; target of rapamycin, Ser/Thr kinase, redox-regulation, disulfide bond, transferase; NMR {Saccharomyces cerevisiae} PDB: 2kio_A 2kit_A Length = 33 Back     alignment and structure
>2npu_A FKBP12-rapamycin complex-associated protein; four-helix bundle, transferase; NMR {Homo sapiens} Length = 126 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query1989
2x6h_A696 GH13170P, VPS34, phosphotidylinositol 3 kinase 59F 100.0
1e7u_A961 Phosphatidylinositol 3-kinase catalytic subunit; p 100.0
2wxf_A940 Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca 100.0
2y3a_A1092 Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca 100.0
3ls8_A614 Phosphatidylinositol 3-kinase catalytic subunit ty 100.0
3hhm_A1091 Phosphatidylinositol-4,5-bisphosphate 3-kinase cat 100.0
1w1n_A33 Phosphatidylinositol 3-kinase TOR1; target of rapa 99.51
2npu_A126 FKBP12-rapamycin complex-associated protein; four- 99.48
3fap_B94 FRAP, FKBP12-rapamycin associated protein; complex 99.32
1w1n_A33 Phosphatidylinositol 3-kinase TOR1; target of rapa 89.63
>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* Back     alignment and structure
Probab=100.00  E-value=3.3e-44  Score=450.06  Aligned_cols=208  Identities=24%  Similarity=0.411  Sum_probs=181.4

Q ss_pred             CcEEEEEEec-eeEEecCCCCceEEEEEcH-----------------------HHHHHHHHHHhcCCccCCCccceecce
Q 037207          228 GIVTIASFSE-EVSILSTKTKPKKLVILGQ-----------------------MLLQAVNSFLRSSPATRSHSLGIRYYS  283 (1989)
Q Consensus       228 ~~VrI~rF~p-~V~VL~SKqrPRRLtI~GS-----------------------QLFrLINsLL~kdkETRRR~L~IrtYs  283 (1989)
                      +.++|.+|.+ .+.|++|+++||||+|+|+                       |||++||.+|.++    +++|.+++|.
T Consensus       405 p~v~I~~~~~~~~~V~~S~~~P~~l~~~gsD~G~~y~~i~K~gDDLRQD~rv~Ql~~lmn~il~~~----~~~L~i~~Y~  480 (696)
T 2x6h_A          405 PEIYITKIVPMRTSLFKSALMPAKLTFVTSIAHHEYAAIFKHGDDLRQDQLILQMITLMDKLLRRE----NLDLKLTPYK  480 (696)
T ss_dssp             TTSEEEEECGGGCEECSSSSCCEEEEEEETTTTCEEEEEEECSSCTHHHHHHHHHHHHHHHHHHHT----TCCCCCCCCC
T ss_pred             CCeEEEEEecCeEEEcccccCCeEEEEEecCCCCceeEEEecCcccchhHHHHHHHHHHHHHHHhC----CCCcEEeccE
Confidence            3489999996 6999999999999999986                       9999999999987    4799999999


Q ss_pred             eeEecCCcceeeecCCcccHHHHHHHHHHHHHHHHHhhhccCCCCCCCCCCCCCCchhhhhhhhHHHHhhcccccccCCC
Q 037207          284 VTPISGRAGLIQWVDNVISIYSVFKSWQHRAQLAQFSAIGAGNAKSSVPPPVPRPSDMFYGKIIPALKEKGIRRVISRRD  363 (1989)
Q Consensus       284 VIPLSp~sGLIEWVpntvTL~eIyk~~~~R~~i~q~~~~~~~n~k~~~~~~vprP~dlfy~kl~~aLke~gi~~v~sR~d  363 (1989)
                      |||+++++||||||++ .||++|++.|..                          ...|                     
T Consensus       481 Vipls~~~GLIE~V~s-~tl~~i~~~~~~--------------------------l~~~---------------------  512 (696)
T 2x6h_A          481 VLATSSKHGFLQYVDS-CTVAEVLAREGN--------------------------IHNF---------------------  512 (696)
T ss_dssp             EEESSTTCEEEECCCC-EEHHHHHHHSSS--------------------------HHHH---------------------
T ss_pred             EEeccCCCCeeeeCCC-ccHHHHHHhcCh--------------------------HHHH---------------------
Confidence            9999999999999975 799999975410                          0001                     


Q ss_pred             CChHHHHHHHHHHHhccchhhHHHHHHhhcCChhHH----HHHHHHHHHhhhhHHHHHhhcccCCCCCCceEEecCCCcE
Q 037207          364 WPHDVKRKVLLDLMKEVPRQLLHQEIWCASEGFKAF----SLKLKRYSESVAAMSMVGHILGLGDRHLDNILLDFSSGDI  439 (1989)
Q Consensus       364 wp~evkreVF~eL~ketP~dlL~r~Lw~~S~sse~w----~~~RknFTrSLAVmSmVGYILGLGDRHPsNILIDr~TGeV  439 (1989)
                                               |....+++..|    ..+|++|++|+|+|||+|||||||||||+||||| .||+|
T Consensus       513 -------------------------f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YILGlGDRH~~NILid-~tG~v  566 (696)
T 2x6h_A          513 -------------------------FRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLLGVGDRHLDNLLLT-TNGKL  566 (696)
T ss_dssp             -------------------------HHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHHTCCCCCTTTEEEC-TTSCE
T ss_pred             -------------------------HHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHccCCCCCCcceEEe-CCCCE
Confidence                                     11111122222    2578999999999999999999999999999999 69999


Q ss_pred             EEEecccccccCCCCcCCCcCCccccHHHHHHhccCCccc--hHHHHHHHHHHHHhhChhHHHHHHHHHhhCCCccccc
Q 037207          440 VHIDYNVCFDKGQRLKVPEIVPFRLTQTIEAALGLTGIEG--TFRANCEAVVSVLRKNKDILLMLLEVFVWDPLIEWTR  516 (1989)
Q Consensus       440 VHIDFG~cFekGkrL~vPE~VPFRLTrNIv~ALGptGVEG--~FRssceatmr~LRknkd~LlsLLEaFVrDPLvdW~~  516 (1989)
                      ||||||+||+.+   +.||+|||||||||+++||+.|++|  .|+.+|+.++++||+|++.|+++|++|++||+.+|..
T Consensus       567 ~HIDFG~~f~~~---p~pe~VPFRLT~~mv~~mG~~g~eg~~~Fr~~c~~~~~~LR~~~~~il~ll~lml~~~lp~~~~  642 (696)
T 2x6h_A          567 FHIDFGYILGRD---PKPMPPPMKLSKEMVEAMGGISSEHHHEFRKQCYTAYLHLRRHANVMLNLFSLMVDATVPDIAL  642 (696)
T ss_dssp             EECCCCSCTTCC---SSSCCCSSCCCHHHHHHTTSSSSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHTTTCCCTTTTS
T ss_pred             EEEeehhhhccC---CCCcCCCeecCHHHHHHhCCCCcccHHHHHHHHHHHHHHHHhCHHHHHHHHHHHHcCCCCcccc
Confidence            999999999887   4699999999999999999999998  5999999999999999999999999999999999974



>2wxf_A Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca subunit delta isoform; transferase, phosphoprotein, isoform-specific inhibitors; HET: 039; 1.90A {Mus musculus} PDB: 2wxg_A* 2wxh_A* 2wxi_A* 2wxj_A* 2wxk_A* 2wxl_A* 2wxm_A* 2wxn_A* 2wxo_A* 2wxp_A* 2wxq_A* 2wxr_A 2x38_A* Back     alignment and structure
>2y3a_A Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca subunit beta isoform; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} Back     alignment and structure
>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A Back     alignment and structure
>3hhm_A Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_A 2rd0_A 4a55_A* 2enq_A Back     alignment and structure
>1w1n_A Phosphatidylinositol 3-kinase TOR1; target of rapamycin, Ser/Thr kinase, redox-regulation, disulfide bond, transferase; NMR {Saccharomyces cerevisiae} PDB: 2kio_A 2kit_A Back     alignment and structure
>2npu_A FKBP12-rapamycin complex-associated protein; four-helix bundle, transferase; NMR {Homo sapiens} Back     alignment and structure
>3fap_B FRAP, FKBP12-rapamycin associated protein; complex, gene therapy, cell cycle; HET: ARD; 1.85A {Homo sapiens} SCOP: a.24.7.1 PDB: 2fap_B* 2rse_B 1nsg_B* 4fap_B* 1aue_A 2gaq_A 1fap_B* Back     alignment and structure
>1w1n_A Phosphatidylinositol 3-kinase TOR1; target of rapamycin, Ser/Thr kinase, redox-regulation, disulfide bond, transferase; NMR {Saccharomyces cerevisiae} PDB: 2kio_A 2kit_A Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 1989
d1e7ua4369 d.144.1.4 (A:726-1094) Phoshoinositide 3-kinase (P 5e-31
d1e7ua4369 d.144.1.4 (A:726-1094) Phoshoinositide 3-kinase (P 0.001
d3fapb_94 a.24.7.1 (B:) FKBP12-rapamycin-binding domain of F 5e-04
>d3fapb_ a.24.7.1 (B:) FKBP12-rapamycin-binding domain of FKBP-rapamycin-associated protein (FRAP) {Human (Homo sapiens) [TaxId: 9606]} Length = 94 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query1989
d1e7ua4369 Phoshoinositide 3-kinase (PI3K), catalytic domain 100.0
d3fapb_94 FKBP12-rapamycin-binding domain of FKBP-rapamycin- 99.34
>d3fapb_ a.24.7.1 (B:) FKBP12-rapamycin-binding domain of FKBP-rapamycin-associated protein (FRAP) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure